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Executive Summary 
The Problem 
Glässer’s disease is still a major problem in the pork industry. Key impacts of this disease 
are:  
• Mortalities as high as 1-2%, despite the use of antibiotics.  In some cases, mortality 
rates as high as 5.4% for post weaning and as high as 11% for pre-weaning have been 
reported 
• Retardation in growth 
The current killed vaccines, besides being expensive, only give protection if all the strains 
present on the farm are included in the vaccine. 
The Project 
The objective of t his pr oject was to r educe pr oduction c osts and improve herd f eed 
conversion efficiency by offering a solution to farmers for the control of Glässer’s disease.  
The solution is controlled exposure of piglets to a live strain of Haemophilus parasuis while 
they are still under the protection of maternal antibodies.  C ontrolled exposure will give 
the piglets protection against the serovars on the farm but will also give cross-protection 
to other serovars.  T herefore, if another serovar is introduced onto the farm, the results 
will not be catastrophic. 
Field trials on four farms have confirmed that the approach is safe, even when pathogenic 
isolates ar e use d.  However, t he f ield t rials hav e no t be en abl e t o de monstrate t he 
efficacy o f c ontrolled e xposure.  T his has o ccurred be cause o f t he di fficulty o f 
demonstrating statistical validity for a disease that often is variable in expression. 
Achievements 
Even though t he f ield t rials o nly g ave i ndications t hat t he m ethod has e fficacy, t he 
knowledge gained during the trials is currently helping pig farmers.   
Major adv ances ar e a s uite o f di agnostic and s upport t ools f or pi g v eterinarians de aling 
with Glässer’s disease. 
 
1. A ne w i mproved P CR a ssay has be en de veloped.  T his R eal T ime P CR i s m uch m ore 
sensitive and spe cific t han t he e xisting c onventional P CRs.  T he m ethod has be en 
validated for direct application to systemic sites and lungs and is available for use. 
2. A serovar profiling service has been developed and is now available.  This involves the 
submission o f nasal  s wabs f rom pi gs at  w eaning and al so f rom di seased pi gs.  I f H. 
parasuis is a pr oblem on the farm, isolates are obtained and the serovars present on 
the f arm are determined.  A recommendation on  which o f t he se rovars sho uld be  
included into an aut ogenous vaccine is provided.  This service has now been provided 
for 23 farms successfully. 
3. A H. parasuis genotyping service has been developed and is now available.  This service 
can be  use d to unde rstand o n f arm e pidemiology ( is one s train pr esent o n m ultiple 
farms? is an outbreak associated with a novel strain or the re-appearance of previously 
known strain?).  This genotyping (and an expanding data-base of genotypes) will greatly 
improve our understanding and hence our ability to control outbreaks. 
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1. Introduction 
Glässer’s disease is still a major problem in the pork industry.  The latest figures 
from Auspork showed that, despite the use of antibiotics in preventative programs 
(~$0.90 per pig), the level of mortalities can still be as high as 1-2% with a cost of 
$0.50 to $1 per pig.  The retardation in growth costs about $1 to $2 per pig, 
bringing the total of costs to $2.40 to $3.90 per pig.  Mortality rates as high as 
5.4% for post weaning, and as high as 11% for pre-weaning, have been reported 
from some Australian farms.  Autogenous vaccines, besides being expensive, only 
give protection if all the strains present on the farm are included in the vaccine 
(Oliveira and Pijoan 2004).  This project had the objective to reduce production 
costs and improving herd feed conversion efficiency by offering a solution for 
farmers to the control of Glässer’s disease.  The solution is controlled exposure of 
piglets while they are still under the protection of maternal antibodies.  
Controlled exposure will give the piglets protection against the serovars on the 
farm but will also give cross-protection to other serovars.  Therefore, if another 
serovar is introduced onto the farm the results will not be catastrophic.  This 
would mean that the cost of antibiotics is not necessary anymore, and mortalities 
plus growth retardation due to Glässer’s would be avoided.  The heavy use of 
antibiotics has a limited future.  This alternative method does not rely on 
antibiotic use and therefore might lead to an increased demand for high-quality, 
niche Australian pork products.  While commercial and autogenous vaccines, all of 
which are currently inactivated, normally induce satisfactory protection, there are 
key limits and constraints.  Both vaccines will only give protection if all prevalent 
serovars in the herd are used in the vaccine and, if the vaccine is given at the 
right time (Oliveira and Pijoan 2004).  Problems with both commercial and 
autogenous vaccines might arise if the prevalent serovar of the herd changes over 
time. 
In the light of these reported failures and problems with commercial and 
autogenous vaccines and the cross-protection associated with live organisms, an 
alternative to vaccination has been proposed.  Oliveira et al. (2001; 2004) have 
successfully experimented with controlled exposure of 5-day-old piglets to low 
doses of the live strains present in the herd.   This alternative approach resulted 
in piglets inoculated with the herd’s systemic strains having less morbidity and 
mortality than piglets colonised by nose-to-nose contact with inoculated sows.  It 
should be noted that this approach has been used in a multi-valent manner, where 
the controlled exposure was to all genotypically different strains found in the 
herd. We propose to establish the controlled exposure model developed by 
Oliveira et al. (2001; 2004) for Australian herds and take this concept further by 
looking at cross protection. 
The PCR methodology, commonly used for the detection of H. parasuis, cannot 
detect H. parasuis if there are less than 102 bacteria in the sample (Oliveira et al. 
2001).  This relative lack of sensitivity is a problem for the moderately virulent 
serovars of H. parasuis.  The alternative method is the culture method.  However, 
this method has its limitations as it depends on live bacteria.  H. parasuis is not a 
very vigorous bacterium and is very susceptible to higher temperatures.  Hence, if 
the samples can not be obtained from the pig directly after death and, if the 
samples can not be transported to the laboratory immediately, culturing will 
almost certainly fail due to the lowered viability of H. parasuis and the more 
vigorous growth of contaminants.  Hence, in most scenarios, PCR methods have 
distinct advantages over culture.  The sole drawback to PCR is the need for at 
least 100 cells.  Therefore, we have developed a more sensitive PCR – a Real Time 
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PCR assay.  This PCR was designed and initially validated on pure cultures.  The 
PCR was validated on samples previously collected from pigs challenged with 
H. parasuis, which had corresponding culture results. 
Work on this project extended beyond the original aims of the project, as other 
infected farms had to be identified and brought into the project.  This required 
knowledge of the H. parasuis status on the farms.  To gain this knowledge a 
serovar profiling method for farms had to be established.  This tool could then be 
used to establish the serovars present on the farms and serovar profile each farm. 
This report will describe all experiments conducted on the four farms involved and 
also report the serovar profiling method and the Real Time PCR.  Detailed reports 
for farm experiments, the serovar profiling method and the Real Time PCR are in 
the appendices.  The general report provides an overview of the project, 
methodology common to all experiments, summary of results for all experiments 
and newly developed methods and also provides an overview of the overall project 
outcomes and applications. 
 
2. Methodology 
Preliminary sampling to establish serovars present on farm 
Nasal swabs were either taken from pigs from multiparous sows at weaning time 
or from sick pigs displaying symptoms typically seen in Glässer’s disease (e.g. 
coughing, anorexia).   The sample sizes varied as it depended on the number of 
multiparous sows available on the day and on the number of sick pigs that had 
signs that were possibly associated with Glässer’s disease.  Necropsies were 
performed on some farms at the same time as sampling was done.  The pigs 
necropsied were extremely sick pigs displaying symptoms typically seen in 
Glässer’s disease.  Swabs of tissue were taken and brought to the laboratory.  All 
swabs were then processed as detailed below.  Sick animals for sampling were 
selected on the basis of showing clinical signs and there was no attempt made to 
definitely establish the cause of the clinical signs.   
Swabs were placed in Amies transport media and kept on ice until inoculated on to 
BA/SN agar, prepared as previously described (Turni and Blackall, 2007) and on to 
blood agar; the latter being cross-streaked with a nurse colony of Staphylococcus 
hyicus.  The plates were then incubated aerobically for 18 - 24 hours at 37ºC.  
Suspect colonies of H. parasuis were selected and sub-cultured on BA/SN for DNA 
processing, storage, identification and serotyping. 
Colonies were prepared for PCR as previously described.  Isolates were confirmed 
as H. parasuis by the PCR of Oliveira et al. (2001).  The ERIC PCR, as described by 
Oliveira et al. (2003), was used to group the strains within one farm according to 
genotype profile.  The genotype profile was compared only within each farm and 
the interpretation performed according to Oliveira et al. (2003).  If two isolates 
had the same genomic fingerprint, i.e. an identical band pattern including 
location and intensity, they were assumed to be the same strain.  For multiple 
sampling on a farm the known genotypes were run as controls in the ERIC PCR.  If 
only small numbers of H. parasuis were being compared and the differences were 
quite obvious, then gels were analysed by eye.  Otherwise the Bionumercis 
software (Bionumeric version 4.50, Applied Maths Inc, Sint-Martens-Latem, 
Belgium) was used to analyse the gels.  Within each genotype detected on a farm, 
representative isolates were serotyped by gel diffusion (GD) testing (Turni and 
Blackall, 2005).  If a clear cut answer could not be obtained, the isolates were 
  3 
then examined by the indirect haemagglutination (IHA) test (Turni and Blackall, 
2005).  Isolates which did not react in any of the tests were regarded as non-
typable and were termed serovar NT. 
The pathogenicity of the serovars was allocated according to the classification of 
Kielstein and Rapp-Gabrielson (1992) with serovars 1, 5, 12, 13 and 14 being highly 
pathogenic, serovars 2, 4 and 15 being moderately pathogenic, serovar 8 being 
slightly pathogenic and serovars 3, 6, 7, 9 and 11 being non-pathogenic. 
Farm 1 
The serovar 4 H. parasuis strain from farm 1 was revived from -70°C storage three 
days prior to preparation onto BA/SN agar.  It was sub-cultured twice on chocolate 
agar plates, that consisted of BBLTM Blood Agar Base (Becton Dickinson, Sparks, MD 
USA), 5 % defibrinated sheep blood (Bio-Lab, Melbourne VIC) and 0.0025% reduced 
nicotinamide adenine dinucleotide (NADH) (Roche Diagnostics, Mannheim 
Germany), with 18 hours incubation at 37°C.  H. parasuis was harvested into 2 ml 
of phosphate buffered saline and then diluted to a concentration of 1 x 104 colony 
forming units (cfu)/ml.  A sample of the prepared inoculum, as well as samples of 
the left over inoculum, was plated onto chocolate agar plates and a count 
performed after one day incubation.  The inoculum was kept on ice until being 
used for inoculation three hours after preparation.  Survival counts showed that 
the prepared inoculum was at the same concentration for this period if kept on 
ice.  A 0.5 ml dose of the inoculum was sprayed into each nostril of the pigs, with 
the total dose per pig being 1.0 ml. 
Farm 2 
The H. parasuis strain from the farm was confirmed as serovar 6 in the GD test but 
was a serovar NT in the indirect IHA.  Three days prior to the controlled exposure 
day, the strain was revived from -70°C storage three by inoculation onto BA/SN 
agar.  It was sub-cultured onto chocolate agar plates (prepared as above) twice 
and was harvested after 18 hours incubation at 37°C (as described above).  The 
H. parasuis was adjusted to a concentration of 7 x 105 cfu/ml.  All other 
procedures for sample handling, controlled exposure and viable counting were as 
described above.  The preparation was used within four hours.  Survival counts 
showed that the prepared inoculum was at the same concentration for this period 
if kept on ice. 
Farm 4 
Three days before the controlled exposure day, the serovar 9 H. parasuis strain 
from the farm was revived from -70°C storage by inoculation onto BA/SN agar.  It 
was sub-cultured on chocolate agar plates (prepared as above) twice before being 
harvested after 18 hours incubation at 37°C.  The H. parasuis was harvested as 
above and adjusted to a concentration of 7 x 105 cfu/ml.  All other procedures for 
sample handling, controlled exposure and viable counting were as described 
above.  The preparation was used within three and a half hours.  Survival counts 
showed that the prepared inoculum was at the same concentration for this period 
if kept on ice. 
Experimental Set-up 
Sows were inoculated with the strain of H. parasuis used for controlled challenge 
three and five weeks before farrowing.  Before farrowing the sows were split into 
two groups (control and treatment group), which were separated by space in the 
farrowing sheds.  Five to seven days after birth, the piglets of the treatment group 
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were challenged with a strain from the farm (see above), which had been used to 
vaccinate the sows. 
A day before or on the day of weaning a subset of piglets from each group were 
nasal-swabbed.  The effectiveness of the controlled exposure was evaluated by 
number of pigs displaying clinical signs possibly related to H. parasuis infection, 
number of antibiotic treatments and pig mortality.  Nasal swabs of sick pigs were 
taken twice a week to find a correlation to H. parasuis infection.  A sub-sample of 
pigs was weighed after leaving the weaning sheds. 
Real time PCR 
The specificity of a real time PCR amplifying the infB gene was evaluated with 68 
H. parasuis isolates and 36 strains of closely related species.  As well, 239 samples 
of DNA from tissues and fluids of 16 experimentally challenged animals were 
tested with the real time PCR, and the results compared with culture and a 
conventional PCR.  For more details see Appendix 6. 
 
3. Outcomes 
Safety of the controlled exposure method 
The safety of the controlled exposure was tested with a moderately pathogenic 
strain on farm 1 and with non-pathogenic strains on farms 2 and 4.  None of the 
controlled challenge pigs showed any signs of illness due to Glässer’s disease.  In 
the dosage trial performed on farm 4, piglets aged 6 days were given dosages as 
high as 109 cfu/ml and these piglets showed no sign of disease.   
Farm 1 
Controlled exposure 
This farm has a serovar 4 disease causing strain, which was used as the controlled 
challenge strain and also in the vaccine used for the sows.  None of the pigs, from 
the control group or the treatment group (controlled challenged pigs) displayed 
any signs of Glässer’s disease during the experiment; which lasted 66 days post 
controlled challenge.  As the sows from both groups were vaccinated with the 
serovar 4 strain, it is not surprising that none of the pigs displayed any signs of 
Glässer’s disease.  The farm also had a non-typable (NT) strain of H. parasuis that 
was spreading rapidly among the pigs.  This strain seemed non-pathogenic as no 
pigs in either group, as well as, any of the pigs in the two rooms where the two 
groups were kept, showed any sign of Glässer’s disease.  The serovar 4 was 
present in some of the pigs that were not controlled exposed (6/23 animals from 
the control group) at 72 days of age.  It might have been present before, but not 
detected due to the presence of the NT strain of H. parasuis. 
From both the treatment and control group the non-typable strain could only be 
found in the nasal cavity when the pigs had entered the weaning rooms.  This, and 
the fact that only one high parity sow out of ten transmitted the non-typable 
strain to her off-spring (preliminary sampling to establish serovars on farm) would 
suggest that the strain does not have a very high prevalence on the farm.  This 
imbalance in the spread of different strains has not been observed previously and 
might be an important issue in the epidemiology of the disease.  The farm had 
been experiencing problems with H. parasuis despite vaccination.  However, no 
Glässer’s disease problems were seen in these pigs.  The rapid spread of the NT 
strain could have been linked with the absence of clinical Glässer’s disease. 
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Farm 2 
Controlled exposure trials 
On this farm the controlled exposure trial was performed twice.  In the first 
experiment the control group consisted of 193 animals, while the treatment group 
consisted of 207 animals.  In the second trial the numbers were 199 and 217, 
respectively.  In the first experiment more animals from the treatment group 
were treated with antibiotics than from the control group (26/15).  In the second 
experiment more of the control group had to be treated (10/ 16).  No post-
weaning deaths were recorded in the experiments.  
In the preliminary serovar profiling work on this farm, 12% of the samples did not 
yield H. parasuis.  This suggests that 12% were possibly naïve and susceptible to 
Glässer’s disease; a figure which matched the prevalence of the cases of Glässer’s 
disease.  Eight serovars were recovered on the farm in this preliminary sampling.  
When the controlled exposure experiments were performed, the percent of 
samples not yielding H. parasuis decreased (see Table 1) and the number of 
serovars recovered increased to 14 serovars with 18 genotypes.   The number of 
naïve and susceptible pigs (% not yielding H. parasuis) did not match the number 
of pigs that needed treatment (possible cases of Glässer’s disease)  
Table 1.  Results of the two experiments on Farm 2 
Experiment Group Group 
size 
% not yielding 
H. parasuis at weaning 
% sick pigs 
after weaning 
1 control 179 1.9 8.4 
treatment 186 2.1 14 
2 
 
control 176 8.7 9.1 
treatment 193 4.0 5.2 
 
H. parasuis is a problem on most farms about 7 - 14 days after weaning.  This farm 
seems no exception to this.  In the preliminary sampling, isolates of serovars 12, 
15 and NT were obtained from nasal swabs of sick picks, with the necropsy 
yielding an isolate of serovar 15.   Experience with serovar profiling farms has 
indicated that if there is a problem with H. parasuis on a farm then nasal 
swabbing sick pigs seems to yield pathogenic strains as is seen in the preliminary 
sampling of this farm (isolates of serovars 12 and 15 are generally regarded as 
pathogenic).  As the serovar 15 isolate was obtained from a necropsy sample, it is 
reasonable to assume that this serovar is causing problems on the farm.  The 
interesting observation in both experiments was that sampling sick pigs from the 
control group yielded isolates of serovar 15, while none of the sick pigs from the 
treatment group yielded this serovar.  Especially in the second trial, it became 
apparent that the majority of sick pigs in the treatment group did not yield H. 
parasuis after weaning and if then it was the serovar distributed by the sow with 
the exception of serovar 13 (Table 2).  This serovar was recovered from a sick pig 
at weaning, while all other serovars from sick animals were recovered past 
weaning. 
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Table 2.  Experiment 2  Serovars recovered from the nasal swabs of the sick pig from 
control and treatment group and the percent of pigs displaying the same serovar as piglets 
from the same mother at weaning (some pigs had more than one serovar).  Serovar 6 and 9 
are regarded as non-pathogenic, while serovar 10, 13 and 15 are regarded as highly 
pathogenic 
Group 
(Control/treatment) Serovar 
% of sick pigs with 
this serovar 
% same serovar as piglets 
at weaning from the 
same sow 
C - 46   
C 6 38 0 
C 9/10 8 0 
C 10 8 0 
C 15 23 0 
C NT 8 0 
    
T - 70   
T 6 10 0 
T 10 10 10 
T 13 10 0 
T  NT 10 0 
- H. parasuis not recovered 
In the first trial a lot more pigs of the treatment group were treated with 
antibiotics (all sick pigs received antibiotic treatment, Table 1) than in the control 
group.  The pathogenic serovars in the treatment group were only displayed 
24 days past weaning, except of the serovar 5 or 12, which was seen at 11 and 
15 days post weaning. The control group, on the other hand, displayed pathogenic 
serovars much earlier with the majority being recovered on day 11 post weaning, 
which is the expected period for an H. parasuis outbreak to occur.   It might be 
that these pigs at 22 days past weaning had other problems than H. parasuis. 
Overall, the trials on this farm gave some indication that controlled exposure has 
the potential to work, but the concept needs to be proven on a farm that has an 
acute problem with H. parasuis and were most of the pigs are not colonized with a 
strain of H. parasuis. 
Table 3.  Experiment 1  Serovars recovered from the nasal swabs of the sick pig from both 
groups – treatment and control (T and C).  Each row represents the serovar recovered from 
one pig at one day of sampling.  Pathogenic serovars highlighted in gray. 
group serovar 
same as 
sow 
days past 
weaning group serovar 
same as 
sow 
days past 
weaning 
C NT YES 0 T 9 NO 0 
C NT YES 0 T 5 or 12 NO 11 
C NT YES 0 T 9 YES 11 
C 9 YES 0 T 9 YES 11 
C 9 YES 0 T 9 YES 11 
C 9 YES 0 T 9 NO 11 
C 2/1 NO 4 T 9 YES 15 
C 9/13 YES 4 T 5 or 12 NO 15 
C 15 + 10 YES/NO 4 T 6 YES 24 
C 15 + 10 YES/NO 4 T 6 NO 24 
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group serovar 
same as 
sow 
days past 
weaning group serovar 
same as 
sow 
days past 
weaning 
C 15 YES 4 T 9 + 6 YES/YES 24 
C NT YES 4 T 9/10 NO 24 
C NT YES 4 T 9/10 NO 24 
C NT YES 11 T 10 YES 24 
C NT YES 11 T 10 NO 24 
C 5 or 12 NO 11 T NT NO 24 
C 9 YES 11     
C 9 YES 11     
C 15 + 9 NO/NO 11     
C 15 NO 11     
C 15 YES 11     
C 15 NO 11     
C 13 + 10 NO/YES 15     
C 15 NO 15     
C 10 NO 24     
 
Farm 3 
Large scale experiments were set up with a big pig company on farms in South 
Australia.  However, the farms pulled out of the trials part way through the first 
experiment.  So we were forced to look for more farms in Queensland.  This 
experiment in South Australia involved the serovar profiling of three farms, 
establishing a transport method for the inoculum which guaranteed survival of the 
organism (involved trial runs and survival studies) and preparation of inoculum for 
four weeks (total of 3000 pigs).  It also involved the processing of nasal swabs 
from the first weaned pigs (58 swabs in total), which were processed and the 
genotype established.  Unfortunately, the farms pulled out of the trials and no 
data was available to analyse, and no report was written. 
Farm 4 
Preliminary exposure trial 
In this trial the safety of the method was established with 71 pigs in the treatment 
group and 63 pigs in the control group.  None of the piglets developed symptoms 
of disease after the controlled challenge at 5 days of age. 
The problem of H. parasuis typically becomes apparent on this farm 10 days after 
weaning.  At this stage many pigs have lost weight and if not given antibiotic at 
this stage pigs will start to die.  This trial was no exception with many pigs at 10 
days post-weaning looking anorexic.  A sub-sample of the pigs from both groups 
were classed into good, average and poor condition by the farm manager and 
nasal swabs taken and cultured for H. parasuis (see Table 4). 
  8 
Table 4.  Results of condition classification and nasal swabbing of pigs at 10 days post-
weaning 
Group 
(number 
sampled) 
Good 
condition 
(%) 
Average 
condition 
(%) 
Poor 
condition 
(%) 
H. parasuis 
serovar 1/11 
recovered (%) 
No H. parasuis 
recovered (%) 
Control 
(52) 
54 25 21 48 46 
Treatment 
(39) 
51 36 13 69 31 
 
As these two groups of pigs were in a large igloo with other non-trial pigs, all pigs 
had to be treated when pigs were showing signs of ill-health.  The strain that 
causes disease on the farm is very pathogenic and treatment has to be given early 
otherwise pigs do not recover.  Despite being given a conventional killed vaccine 
and antibiotics in the feed, the non-trial pigs were also falling back and needed 
treatment on day 11 (with this treatment being water medication for the entire 
igloo). 
The aim of this experiment was to establish that the number of sick pigs and the 
mortality rate in the control group would not exceed the death rate observed 
previously on farm.  It was also meant to establish the safety of the controlled 
challenge method. 
None of the pigs died in the experiment.  Four pigs were taken out into the 
nursery to avoid the treatment of antibiotics which had to be given to all pigs in 
the igloo via the water.  These pigs did get the antibiotic in the feed.  Therefore, 
the number of sick pigs taken out was only slightly higher due to our artificial 
intervention (6.3% compared to 3.5%).  In summary, the experiment established 
that the death rate and the number of sick pigs would not markedly increase in 
pigs that are not given the normal vaccine used for the farm and the antibiotics 
used at weaning.  As a result, the management of the farm agreed to allow 
further experiments on the farm. 
In this experiment more pigs of the treatment group than the control group had 
H. parasuis serovar 1/11 in their nasal cavity.  The igloo used in this trial was split 
into two pens, one being for the male and the other for the female pigs.  The 
treatment group was together with the male pigs, while the control group was 
together with the female pigs.  This could have made a difference in the spread of 
the disease and hence the detection of the organism in the nasal cavity.  The 
presence of the organism in their nasal cavity does not mean their immune system 
is not mounting an active response.  Rather, nasal colonization means that 
infection has occurred and it might even invade their lungs, but might not 
necessarily cause sever disease symptoms. 
While both groups had nearly the same percentage of pigs classified as “good 
condition”, the treatment group had fewer pigs in the “poor” group (13% 
compared to 21% of controls) and thus more pigs in the “average” group (36% 
compared to 25% of controls). 
One observation that suggests that the controlled challenge dose is too low is the 
fact that H. parasuis was not recovered from the nasal cavity of the treatment 
pigs two days before weaning.  Therefore, the next step was to establish a 
challenge dose at which all treated pigs become colonized. 
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Dosage Trial 
During the above preliminary trial to test the safety of controlled exposure of 
Haemophilus parasuis, it was discovered that, at weaning, the particular strain 
used for the controlled exposure – a serovar 9 strain – given as a controlled 
exposure (at 5 days of age) in the nostrils of the exposed pigs could not be 
retrieved from the nasal cavity at weaning.  This was an unexpected result.  As 
this could suggest that the dosage rate for the controlled exposure was too low, 
an experiment using a titration of higher dosage levels was performed to establish 
whether higher concentration of the controlled challenge inoculums could be 
retrieved back when sampled just before weaning. 
In this experiment piglets of eight low parity sows, (the sows having been twice 
vaccinated with the strain used for controlled exposure), were controlled exposed 
at the age of 6-7 days after birth.  These sows were separated by space from each 
other.  The off-spring of two sows belonging to one group given the same 
concentration of inoculums.  Four inoculum concentrations were trialled. 
Table 5.  Results of dosage experiment on Farm 4 
Dosage No. of pigs sampled No. with 
H. parasuis 
Serovar 
Sampled one day before weaning 
3.6 x 108 cfu/ml 21 pigs from two low 
parity sow 
0 N/A 
4.3 x 107 cfu/ml 20 pigs from two low 
parity sow 
0 N/A 
0.9 x 108 cfu/ml 20 pigs from two low 
parity sow 
2 9 
1.08 x 109 cfu/ml 22 pigs from two low 
parity sow 
0 N/A 
Sampled 10 days after weaning 
3.6 x 108 cfu/ml 17 1 9 
4.3 x 107 cfu/ml 15 0 N/A 
0.9 x 108 cfu/ml 16 0 N/A 
1.08 x 109 cfu/ml 16 0 N/A 
0 cfu/ml 40 3 9 (2 isolates) 
1/11 (1 isolate) 
The dosage level did not seem to make a difference in the recovery of H. parasuis 
from the nasal cavity.  In the present experiment, only a low level of colonization 
with H. parasuis was detected (two of 83 pigs pre-weaning and 1 of 64 pigs post-
weaning).  This level is around the level that is normally seen on this farm for the 
serovar 9 organism.  As an example, in the preliminary trial two out of 52 control 
pigs were colonised with serovar 9, a prevalence of 3.8%. 
As the inoculum of H. parasuis was still viable upon return to the laboratory, the 
assumption can be made that there was nothing wrong with the inoculum.  Every 
precaution was taken not to negatively affect colonisation, including the 
management not using antibiotic treatment for 7 days after the controlled 
challenge. 
The technique of nasal swabbing only samples the bacteria in the upper part of 
the nasal cavity.  It could be that the bacteria sprayed into the nasal cavity do not 
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colonise in this part of the cavity.  The organism might establish in the lower part 
of the nasal cavity or in the tonsils and even trachea. 
The low prevalence of serovar 1/11 in the control pigs, which should at day 
10 after weaning come down with Glässer’s disease, is noteworthy.  In the 
preliminary trial 25 pigs out of 52 control pigs had serovar 1/11, which is a 
prevalence of 48%. 
On the farm there are now sows coming through that have been vaccinated twice 
again since the strain was left out of the vaccine and caused the outbreak of 
Glässer’s disease on the farm. 
Serovar profiling method 
The objective of this component of the project was to investigate the diversity of 
Haemophilus parasuis serovars present in pig herds using nasal swabbing.  Nasal 
swabs were used to obtain multiple isolates of H. parasuis which were grouped 
first by genotyping with representative isolates then being serotyped.  Swabs were 
taken from the nasal cavity of just-weaned healthy pigs from multiparous sows 
from 12 farms and from post-weaned pigs of multiparous sows on one farm.  On 
five out of these 13 farms, nasal swabs were also obtained from pigs showing 
clinical signs suggestive of Glässer’s disease.  On a further seven farms, nasal 
swabs were obtained only from pigs with clinical signs suggestive of Glässer’s 
disease. 
A total of 556 H. parasuis isolates were genotyped, while 150 isolates were 
serotyped.  H. parasuis was detected on 19 of 20 farms, including two farms with 
an extensive history of freedom from Glässer’s disease.  Isolates of H. parasuis 
belonging to serovars regarded as potentially pathogenic were obtained from 
healthy pigs at weaning on 8 of the 10 farms with a history of Glässer’s disease 
outbreaks.  Sampling 213 sick pigs yielded 115 isolates of H. parasuis.  Ninety-nine 
of these isolates belonged to serovars that were either potentially pathogenic or 
of unknown pathogenicity.  Only 16 isolates from these 213 sick pigs were of a 
serovar known to be non-pathogenic.  Healthy pigs contain a range of H. parasuis, 
even on farms free of Glässer’s disease.  Nasal swabbing of both healthy and sick 
pigs seems a useful tool to serovar profile farms. 
Real Time PCR 
The aim of this study was to validate a real time PCR test for the diagnosis of 
Glässer’s disease, a major pig disease caused by Haemophilus parasuis.  The 
specificity of a real time PCR amplifying the infB gene was tested with 
68 H. parasuis isolates and 36 strains of closely related species.  As well, 
239 samples of DNA from tissues and fluids of 16 experimentally challenged 
animals were tested with the real time PCR, and the results compared with 
culture and a conventional PCR. 
The real time PCR gave positive results for all 68 H. parasuis isolates and negative 
results for all 36 non-target bacteria.  When used on the clinical material from 
experimental infections, the real time PCR produced significantly more positive 
results than the conventional PCR (165 compared to 86).  The sensitivity of the 
real time PCR combined with high specificity makes it a very valuable tool for the 
diagnosis of Glässer’s disease.  This new method will improve the ability of 
laboratories to diagnose Glässer’s disease, especially in laboratories where the 
culture method for H. parasuis is not optimal. 
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Summary 
The recently released Actinobacillus pleuropneumoniae vaccine method has 
proven that live vaccination with fully virulent field isolates can work.  The same 
principle applied in the A. pleuropneumoniae is applied in the controlled 
challenge model for H. parasuis.  Piglets are challenged with a strain while under 
the protection of the maternal antibodies.  They then get colonised and develop 
their own immunity.  The situation for H. parasuis is a bit more complicated than 
for A. pleuropneumoniae as most farms have more than one pathogenic 
H. parasuis strain and vaccine needs cross-protection against other strains on the 
farm.  Farm trials seeking to prove the efficacy of a vaccination program need to 
be performed on farms that have an acute outbreak of the disease.  The control 
group needs to be severely affected by Glässer’s disease to give statistical 
significance, especially if small groups (200 animals per group) are used.  As some 
of the Glässer’s disease symptoms could also be associated with other diseases 
(like anorexia) it is important that the symptoms are more specific to the disease.  
The only other way is to have huge numbers of pigs participating in the trial.  
Alternatively, the trial could be conducted under pen conditions at a research 
facility.  In such a research facility, other variables can be held constant and 
therefore, small groups should give statistically significant results. 
 
Despite extensive efforts, no farm trial in the current project resulted in a frank 
outbreak of confirmed Glässer’s disease in the control group.  This absence of 
frank disease in the control group meant that it was impossible to demonstrate 
the efficacy of the controlled exposure concept. 
4. Application of Research 
The knowledge gained during the project is currently helping pig farmers. 
Major a dvances achieved i n t he pr oject w ere a sui te o f di agnostic an d suppo rt 
tools for pig veterinarians dealing with Glässer’s disease. 
1. A ne w i mproved PCR assay  has  be en de veloped.  T his R eal T ime P CR i s 
much more sensitive and specific than the existing conventional PCRs.  The 
method has be en v alidated f or di rect appl ication t o sy stemic si tes and 
lungs and is available for use. 
2. A serovar profiling service has be en developed and is now available.  T his 
service involves the submission of nasal  sw abs from pi gs a t w eaning a nd 
also from diseased pigs.  If H. parasuis is a problem on the farm, the 
organism will be isolated and the serovars present on the farm determined.  
A recommendation on  which o f t he se rovars sho uld be  i ncluded i nto an  
autogenous vaccine will be  provided.  This service has be en provided for 
23 farms to date. 
3. A H. parasuis genotyping service has been developed and is now available.  
This service can be used to understand on farm epidemiology (is one strain 
present on multiple farms? is an outbreak associated with a novel strain or 
the re-appearance o f previously known st rain?).  T his genotyping ( and an 
expanding data-base of genotypes) will greatly improve our understanding 
and hence our ability to control outbreaks. 
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5. Conclusion 
Safety of the controlled exposure method 
The experiments demonstrated without a doubt that this method is safe to use 
when using moderately pathogenic and non-pathogenic strains.  Even at very high 
concentration of the inoculums, the method was safe and no signs of illness were 
observed.  If using highly pathogenic strain, the presence of maternal antibodies is 
vital for the safety of the method.  On a commercial piggery, not all piglets will 
have their fair and equal share of maternal antibodies.  Hence, the use of a highly 
pathogenic strain as a control exposure agent might not be as safe.  The research 
to date has shown that most farms have non-pathogenic strains or moderately 
pathogenic strains, suggesting that there is no need for the use of highly 
pathogenic strains. 
Controlled exposure 
The experiment on Farm 2 highlighted the diversity of serovars of H. parasuis that 
could be found on a farm (14 different serovars).  This farm had the highest 
diversity of serovars detected on the 20 farms sampled in this project; the 
average across all farms being three serovars per farm.  It also highlighted the 
changes of serovar within batches of pigs with some of the serovars that are at 
low frequency only appearing in some batches of pigs. This indicates the 
importance of sampling more than one batch of piglets to avoid low frequency 
serovars being missed.  It is possible that some of the failures of autogenous 
Glässer’s vaccines that have been observed on farms could be due to the fact that 
not all serovars present on the farm were incorporated in the vaccine. 
Even though the Farm 2 experiment did not prove that the controlled exposure 
method worked, it certainly gave an indication that the method could work.  None 
of the sick pigs from the treatment group yielded serovar 15, which is a disease-
causing serovar on the farm, while some of the sick pigs of the control group in 
both experiments yielded this serovar. 
Another important point that emerged from this experiment is that the farm to be 
used in further experiments has to have an acute problem with H. parasuis to 
allow a demonstration of vaccine efficacy. 
The preliminary experiment on Farm 4 highlights several points.  One point is that 
the ability of a serovar to spread among pigs (essentially, its frequency of 
detection) is a very important point in the control of the organism.  A strain that 
is easily spread, a good colonizer, and has a high pathogenicity, as seen on this 
farm, is likely to be difficult to control.  In contrast, Farm 1 had a non-pathogenic 
strain which spread rapidly, while the pathogenic strain could only be found when 
sampling was increased.  A strain that is non-pathogenic and spreads easy would 
be an ideal strain for a vaccine, as it would give protection, and would easily 
spread amongst pigs, particularly if it is the first strain encountered by the naïve 
pig.  It is possible that such “super colonizers” might exclude or prevent other 
strains from colonizing. 
The dosage trial on Farm 4 showed that the colonization in the nasal cavity did not 
seem to depend on the dosage level.  However, on Farm 2, a colonization of 32 % 
was achieved in the first trial, even though a dose of only 7 x 105 cfu was used, 
compared to the low colonization level of 2.4% in the dosage trial on Farm 4.  The 
Farm 2 and Farm 4 trails were performed with different serovars (6 and 9 
respectively).  It is not clear whether colonization in the nasal cavity depends on 
the strain or other factors.  Indications seen throughout these experiments suggest 
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that the detectable presence of the vaccine strain in the nasal cavity might not be 
essential for the protective immunity. 
Serovar profiling method 
H. parasuis is part of the natural flora of the upper respiratory tract of pigs, so it 
is not surprising that H. parasuis was found in the nasal cavity of weaned pigs on 
two farms with an extensive history of freedom from Glässer’s disease.  Strains 
that spread rapidly will make it hard to find strains with low prevalence.  
Therefore, a large sample size is needed to find low prevalence strains indicating 
that multiple serovars may not easily be detected if one strain is more prevalent 
than the others.  Clearly, the question arises of how many colonies have to be 
sampled to find strains circulating at a low prevalence.  The result of the current 
study, that many isolates of H. parasuis can be obtained from a given herd, but in 
most cases only one or two strains predominate, coincides with the finding of 
Smart and Miniats (1993).  Except for a few limited studies, such as on the 
colonisation rate of weaned pigs (Kirkwood et al. 2001; Cegielski et al. 1999), and 
attempts to determine the prevalent serovars in pigs (Kirkwood et al. 2001; Smart 
et al. 1988; Olvera et al. 2006), there is no actual study looking at the diversity 
within individual pigs across several farms with more than two serovars; nor are 
there any studies of the prevalence of strains over time.  Therefore, there is no 
guidance as to how many samples have to be taken to establish the serovars 
present in a pig, especially if one strain is dominant. 
Sampling sick pigs which showed clinical signs suggestive of Glässer’s disease 
yielded only strains of serovars regarded as pathogenic and serovar NT when the 
first 13 farms were evaluated.  Despite the dominant serovar NT strain on Farm 1, 
the pathogenic serovar 4 strain on this farm was recovered effortlessly in the nasal 
cavity of a sick pig (only one colony was collected).  These results, combined with 
the fact that pathogenic strains of H. parasuis given in artificial challenges can be 
found in the nasal cavity (Oliveira et al. 2001; Segales et al. 1997), suggest that 
there is definitely a correlation between sick pigs and the presence of pathogenic 
serovars of H. parasuis in the nasal cavity.  Overall, it seems that strains of 
H. parasuis of known pathogenic serovars can be found in the nasal cavity of sick 
pigs and are most likely disease-causing strains. 
The multiplicity of serovars found on Australian pig farms was higher than other 
researchers have observed.  Smart et al. (1988) observed that most farms 
harboured two to four strains.  Most of the farms in the current studies conform to 
the observation of Smart et al. (1988).  Oliveira et al. (2003) looked at 10 herds in 
America and recovered 1 to 3 serovars per herd. 
Our results suggest that the serovar can change in time if certain strains are used 
for vaccination.  These changes in serovar prevalence might have to do with the 
normally low prevalence of pathogenic strains in healthy animals (Oliveira and 
Pijoan 2002) while diseased animals might have a higher prevalence of pathogenic 
strains.  A study by Olvera et al. (2007) found that the diversity of strains isolated 
on a farm was affected by antimicrobial treatment.  Immediately following 
antibiotic treatment, they could only recover one of the three strains present on 
the farm before antimicrobial treatment and this strain was resistant to the 
antibiotic used.  However, one year after treatment the diversity of the strains 
was back to that seen before the treatment.  This would suggest that the 
susceptible strains were still there at a low prevalence and it stresses the 
importance of serovar profiling to find all the strains that are potentially disease 
causing organisms.  Overall, the results from farms where sick pigs were sampled 
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indicate that both methods (swabbing healthy weaned pigs and sick pigs) should 
be combined to enhance results of the profiling. 
In summary, H. parasuis was found on farms where no outbreak of Glässer’s 
disease had occurred.  Isolates of serovars recognized as being pathogenic can be 
easily missed if another strain is more prevalent.  Detection of isolates occurring 
at a low prevalence requires examining multiple colonies per nasal swab.  
Sampling healthy weaned pigs does not necessarily reveal all pathogenic serovars.  
The sample size of pigs is important in the detection of strains on a farm.  A 
bigger sample size of sick pigs on some of the farms might have revealed all 
pathogenic serovars on the farms. 
Real Time PCR 
The isolation of H. parasuis is difficult, as the bacterium is very sensitive to pH 
changes and heat (Morozumi and Hiramune 1982).  H. parasuis is also a slow 
growing, fastidious organism with specific nutritional requirements (Ferri et al. 
2000; Oliveira and Pijoan 2004).  This makes recovery of the organism after 
sample collection and transport to the laboratory very difficult.  Once in the 
laboratory the isolation is very difficult as H. parasuis is easily overgrown by other 
faster growing bacteria.  Therefore, the method of identification by culture is not 
always optimal and PCR-based methods are an attractive alternative.   The 
available conventional PCR assays display problems with non-specific bands 
(Oliveira et al. 2001) or sensitivity (Angen et al. 2007).  The real time PCR method 
described here is more specific and does not give a positive reaction with any of 
the 24 non-target species (including all close relatives) tested.  Oliveira et al. 
(2001) reported a sensitivity of 0.5 cfu per reaction, while Angen et al. (2007) 
reported a sensitivity of 5.3 cfu per reaction for their respective PCR tests.  
According to our sensitivity assays, the real time PCR showed a sensitivity of 9.5 to 
0.83 cfu per reaction for the boiling method of DNA extraction and 47.5 CFU per 
reaction to 0.42 cfu per reaction for the PrepMan Ultra method.  However, when 
looking at the data from the challenged animals, where the Oliveira et al. (2001) 
PCR was used as well, the real time PCR gave significantly higher numbers of 
positive results than the Oliveira et al. (2001) PCR.  Overall, our data indicate that 
the real time PCR is more sensitive than the conventional PCR, even though our 
minimum detectable cfus per reaction were higher than the reported minimum 
detectable cfus of the conventional PCR (Oliveira et al. 2001). 
In a study by Turni and Blackall (2007), the culture method was deemed more 
successful than the conventional PCR method, when detecting H. parasuis in sick 
animals.  The results of the current study indicate that this does not hold true for 
the real time PCR.  The real time PCR performed better than culture, although not 
at a statistically significantly level for swab samples.  In laboratories where the 
culture methods are not as optimized as in our laboratory, the real time PCR 
should perform even better compared to culture.  Therefore, we believe that real 
time PCR will enhance the diagnosis of H. parasuis, especially for laboratories that 
are not experienced with the culture of H. parasuis or, in situations where culture 
is not possible. 
The sensitivity assay revealed that the real time PCR detected low numbers of 
H. parasuis even in the presence of large numbers of non target cells.  The ability 
of the real time PCR to perform well in the presence of large number of other 
bacteria, was seen in the results obtained from the samples processed from the 
tonsils of the challenged animals.  The real time PCR significantly outperformed 
the conventional PCR-culture method. 
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When using this real time PCR assay as a diagnostic tool it has to be pointed out 
that the presence of H. parasuis in the upper respiratory tract does not mean that 
there is a problem with H. parasuis, as non-pathogenic serovars can be found in 
the upper respiratory tract.  Therefore, if the real time PCR is used as the 
diagnostic tool to determine the cause of disease, the assay should be used from 
samples from internal organs and tissues. 
The infB gene targeted real time PCR for H. parasuis performed well for pure 
culture, swabs from tissue and fluid or tissue and fluid processed directly 
regardless of contamination by other bacterial species.  The high sensitivity and 
specificity of the real time PCR make it an ideal diagnostic tool for H. parasuis.  
The real time PCR has distinct advantages over conventional PCR, such as less risk 
of non-specific reactions and contamination, less handling time (no post-reaction 
analysis) and the potential of high throughput automation. 
Conclusion 
This project has aimed at improving the diagnostic capability to detect H. parasuis 
and t o i mplement a n ew me thod t o c ontrol H. parasuis on Aust ralian f arms.  
During t he pe riod o f t he project t he aim o f better di agnosis has be en f ulfilled.  
Tools l ike the R eal T ime P CR, se rovar p rofiling and g enotyping o f H. parasuis, 
have g iven the Aus tralian pig industry the tools t o di agnose H. parasuis and t o 
implement v accine st rategies t o c ontrol t he p roblem.  The k nowledge g ained 
during the project has helped to implement all these tools and make them already 
available to the pig industry well before the end of the project. 
The implementation of the controlled exposure as a v accination method has had 
its difficulties.  The project has been able to generate data that indicates that 
this method will work.  It is certainly a safe method and all the tools are in place 
to determine the serovars on the farm and pi ck a sui table serovar for controlled 
exposure. 
 
6. Limitations/Risks 
Controlled exposure 
So far it has become clear that the method of controlled exposure is extremely 
safe and all the tools are in place to establish the method on a farm.  The 
difficulties in establishing that the method gives statistically significant protection 
are due to the difficulties encountered on the farm with disease outbreaks 
associated with H. parasuis.  Other factors influence the picture H. parasuis 
represents on a farm.  The clinical signs displayed due to H. parasuis infection are 
not very disease specific, but could be associated with other diseases as well. 
The project has shown that for H. parasuis vaccine research on farms, a large 
farm that has an acute outbreak with a large sample size is needed to get 
statistically significant results. 
Diagnostic methods 
The two diagnostic tools that have been developed (Real Time PCR and Serovar 
Profiling) are the tools that were previously missing, and limited the capacity to 
diagnose the disease on farms.  It is now possible for Australian farmers to use 
these tools to aid in the diagnosis of Glässer’s disease.  These tools have to be 
applied with the constraints identified in this project.  As an example, the simple 
presence of H. parasuis in the nasal cavity, as detected by the real time PCR, does 
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not mean that a pig is suffering from Glässer’s disease.  H. parasuis is part of the 
natural flora of the upper respiratory tract of pigs.  Therefore, strains in the nasal 
cavity could be non-pathogenic and not being involved in disease at all.  It is also 
important to think about sample size to make sure all strains on the farm are 
being sampled. 
 
7. Recommendations 
Controlled exposure 
The concept of controlled exposure needs to be tested on a large farm that has an 
acute outbreak and were no other obvious diseases interfere with the outcome.  It 
needs to be a farm where the clinical signs can be attributed to Glässer’s disease 
and where there is still a death rate due to Glässer’s disease. 
For implementation of the method a freeze drying method for H. parasuis needs 
to be developed, as shipping this fastidious organism in a live state is not an easy 
task and has major limits. 
Serovar profiling and Real Time PCR 
Both these methods are available to the pig industry and have already helped pig 
farmers to control their H. parasuis problem. 
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Appendix 1 - Preliminary experiment to test safety of 
controlled exposure method – Farm 1 
 
Glässer’s disease is still a major problem in the pork industry.  Autogenous 
vaccines, besides being expensive, only give protection if all the strains present on 
the farm are included in the vaccine.  The objective of the project is to reduce 
production costs and improving herd feed conversion efficiency by offering a 
solution to farmers for the control of Glässer’s disease.  The solution is controlled 
exposure of piglets while they are still under the protection of maternal 
antibodies.  Controlled exposure will give the piglets protection against the 
serovars on the farm but will also give cross-protection to other serovars.  
Therefore, if another serovar is introduced onto the farm the results will not be 
catastrophic.  This would mean that the high cost of antibiotics to control 
Glässer’s is not necessary any more and mortalities plus growth retardation due to 
Glässer’s would be avoided. 
This report covers a preliminary field trial that was performed chiefly as a safety 
trial.  At six days of age, pigs were exposed – by nasal spray - to the moderately 
pathogenic serovar 4 present on the farm.  The sows had been immunized against 
this serovar prior to farrowing with a killed vaccine that contained the serovar 4 
strain from this farm.  The pigs were then regularly sampled to establish the 
colonization of the challenge strain. 
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Results of sampling 
Date Procedure Days post exposure 
H. parasuis (Hps) 
recovered 
31/7/06 Sampled the nasal cavity of 52 piglets from 10 
sows (4-5 piglets per sow) to establish serovars 
present on the farm. 
14 days 
before 
exposure 
Found Hps in the 
nasal cavity of 
piglets from two 
sows.  This was a 
serovar NT 
(confirmed by gel 
diffusion (GD) and 
Indirect 
Haemagglutination 
assay (IHA)).   
 
The strain that was 
recovered from this 
farm as a disease 
causing strain was 
serovar 4 
14/8/06 Exposed 29 piglets at six days of age to 1.04 x 
104 cfu (delivered in 1 ml dose to nostril) of the 
serovar 4 strain recovered from the farm.  
Piglets were ear marked with purple tags.  All 
pigs were in the same nursery room.  Came 
from 4 sows (0180, W213, 0212, 073). 
 
25 piglets were ear tagged with yellow tags as 
control group.  These piglets were in a 
different room of the nursery.  Came from 5 
sows (0177, 0357, TP1507, Y339, W355).  First 
to third parity sows were used.  
0  
22/8/06 18/8/06 control pig died due to scours.  
20/8/06 control pig died due to scours.  6 
control pigs were treated with Amoxycillin.   
 
Sampled the nasal cavity of 18 treatment and 
23 control piglets.  Found Actinobacillus 
indolicus in the nasal cavity of one treatment 
piglet. Found Actinobacillus rossii in one 
control piglet. 
8 none 
28/8/06 Sampled the nasal cavity of 11 treatment and 
23 control piglets 
 
Sampled nasal cavity of a sick pig in weaner 
room, which was not part of the experiment.  
Clinical signs: held head at strange angle, 
laboured breathing and had been in weaner 
room for longer than normal.  Recovered H. 
parasuis serovar 4 from the nasal cavity of this 
pig. 
 
14 none 
4/9/06 Sampled the nasal cavity of 18 treatment and 
23 control piglets. 
 
2 control pigs (16, 13) and 1 treatment pig (1) 
have A. indolicus in the nasal cavity.   
 
21 none 
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Date Procedure Days post exposure 
H. parasuis (Hps) 
recovered 
11/9/06 Sampled the nasal cavity of 29 treatment and 
23 control pigs.  Prior to sampling control pigs 
(except pig 3 and 23, which had a light weight 
at birth) have been moved to weaner room 
 
28 13 of 23 control pigs 
had serovar NT 
 
8 of 29 treatment 
pigs had serovar NT 
 
20/9/06 Sampled the nasal cavity of 29 treatment and 
23 control pigs.  Prior to sampling treatment 
pigs have been moved to weaner room.  Pig 3 
and 23 are still in nursery. 
 
37 21 of 23 control pigs 
had serovar NT 
 
Pigs 3 and 23 of 
control group were 
free of Hps 
 
17 of 29 treatment 
pigs had serovar NT 
 
26/9/06 Sampled the nasal cavity of 16 treatment pigs 
(ones not positive for Hps last sampling) and 2 
control pigs that were still in nursery last time. 
 
Both control animals were still in nursery.  Rest 
of control pigs were sent to grow out shed, 
while we were there.   
43 14 out of 16 
treatment pigs had 
serovar NT 
 
2 control pigs did not 
have Hps 
2/10/06 Sampled 29 treatment pigs.  Treatment group 
was still in the weaner room. 
 
From each plate collected 6 colonies, which 
were processed and genotyped to find serovar 4 
amongst them. 
 
Also sampled 2 control pigs. 
51 All treatment pigs 
had Hps serovar NT 
 
11 of 29 treatment 
pigs had Hps serovar 
4 
 
2 control pigs had 
Hps 
17/10/06 Sampled 23 control pigs and 21 treatment pigs 
 
From each plate collected up to 6 colonies, 
which were processed and genotyped to find 
serovar 4 amongst them. 
66 All Pig had Hps 
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Results of genotyping 
 
Date Procedure Genotype H. parasuis (Hps) serovar 
28/08/06 Compared the genetic 
profile of the exposure 
strain and the strain 
found in the sick pig (that 
was not part of the 
experiment) with the 
strain found in the pre-
exposure sampling with 
an ERIC PCR  
The serovar 4 of the challenge 
strain has a distinctly different 
genetic profile than the 
serovar NT that was found in 
the pre-exposure sampling. 
 
The genetic profile of the 
strain from the sick pig was 
the same as the exposure 
strain. 
 
11/9/06 Compared the genetic 
profile of Hps recovered 
from the nasal cavity 
from 8 treatment pigs 
and 13 control pigs 
 
All ERIC PCR were run 
with two controls – the 
serovar 4 (exposure 
strain) and the serovar NT 
All except one pig from the 
treatment group had the same 
genetic profile 
The 20 isolates 
showing the 
common genetic 
profile were non-
typable serovar 
(confirmed by 
GD) 
The single 
isolate with the 
different genetic 
profile was also 
confirmed as 
serovar NT by GD 
and IHA.  
20/9/06 Compared the genetic 
profile of Hps recovered 
from the nasal cavity 
from 17 treatment pigs 
and 21 control pigs.  Had 
more than one sample 
(more than one colony 
collected of the original 
culture plate) for some of 
the pigs.  Compared a 
total of 61 isolates. 
All of the animals had Hps with 
the same genetic profile as the 
NT serovar recovered in the 
pre-trial sampling and in the 
previous sampling.   
 
26/9/06 Compared the genetic 
profile of Hps recovered 
from the nasal cavity 
from 14 treatment pigs.  
Compared a total of 51 
isolates 
All of the animals had Hps with 
the same genetic profile as the 
NT serovar recovered in the 
pre-trial sampling and in the 
previous sampling.   
 
2/10/06 Compared the genetic 
profile of Hps recovered 
from the nasal cavity 
from 29 treatment pigs 
and 2 control pigs 
 
Sampled about 6 colonies 
from each original culture 
plate, resulting in a 
comparison of 139 
isolates.  
18 isolates displayed a genetic 
profile identical to profile of 
the serovar 4 strain, while the 
rest of the isolates (121) 
displayed a profile identical to 
the profile of the serovar NT 
strain. 
 
The 18 isolates displaying the 
serovar 4 profile came from 11 
pigs. 
 
 
  23 
Date Procedure Genotype H. parasuis (Hps) serovar 
17/10/06 Compared the genetic 
profile of Hps recovered 
from the nasal cavity 
from 21 treatment pigs 
and 23 control pigs. 
 
Sampled up to 6 colonies 
from each original culture 
plate, resulting in a 
comparison of 193 
isolates. 
  
 
3/21 treatment animals 
yielded Hps that displayed a 
serovar 4 profile as well as Hps 
with the NT serovar profile 
(comparison of 89 isolates).   
 
6/23 control animals yielded 
Hps that displayed a serovar 4 
profile as well as Hps with the 
NT serovar profile (comparison 
of 104 isolates). 
 
For all the rest of the animals 
(18 treatment and 17 controls) 
only Hps with the serovar NT 
profile was found. 
 
 
 
The different genetic profile discovered on the 11/9/06 from one animal might 
have been a mixed culture, as it was the only time this profile appeared and in 
further sampling the genotype recovered from this animal was the normal 
genotype of the NT serovar recovered from all animals during the trial. 
None of the challenged pigs showed any clinical signs associated with Glässer’s 
disease, indicating that the controlled exposure method appears to be safe with 
the moderately pathogenic serovar 4 strain used in this study.   
The spread of the presumably non-pathogenic strain of the NT serovar (none of 
the control group showed any signs of disease) among all pigs of both treatment 
and control groups prevented a differentiation between the groups.  The results 
suggest that this non-typable strain is an ideal candidate for controlled exposure 
due to its rapid spread and safety. 
Conclusion: 
Due to the rapid spread of the non-typable H. parasuis interfering with the 
differentiation of the control and treatment groups and the lack of any sign of 
Glässer’s disease in the control group this farm is unsuitable for the evaluation of 
the controlled exposure method.   
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Appendix 2 - Controlled exposure experiments on 
Farm 2 
Introduction 
Glässer’s disease has in recent times emerged again as one of the major disease 
problems in the pork industry (Nedbalcova et al. 2006).  The disease is associated 
with poly-serositis, poly-arthritis and meningitis.  The causative agent of this 
disease is the bacterium Haemophilus parasuis (Nedbalcova et al. 2006).  Major 
losses occur due to mortalities and poor growing pigs.  The problem is mainly 
observed shortly after weaning (Oliveira and Pijoan 2004).  At this stage pigs 
colonised by H. parasuis, which have developed their own immunity while under 
the protection of maternal antibodies, spread the bacterium to susceptible pigs 
that were not colonised (Oliveira et al. 2001).   
There are 15 serovars of H. parasuis, being either very, moderately, mildly or 
none pathogenic (Kielstein and Rapp-Gabrrielson 1992).  The commercial and 
autogenous vaccines available in Australia are made with killed bacteria and give 
generally protection only to the serovar/s present in the vaccine.  However, 
vaccination with live bacteria is supposed to give cross-protection.  This concept 
that live organisms provide more cross-protection than killed organisms has been 
noted with other bacteria within the family Pasteurellaceae.  Studies with 
Actinobacillus pleuropneumoniae have induced cross-immunity between a variety 
of serovars of this organism after natural respiratory infection (Furesz et al. 1997; 
Prideauz et al. 1999).  Similar results have been reported outside the family 
Pasteurellaceae.  As an example, studies with Neisseria meningitidis, have 
confirmed that infection with live bacteria (mutant virulant strain) gives cross-
protection against a range of strains with different serogroup, serotype and 
serosubtyping antigens (Newcombe et al. 2004).   It was also suggested that the 
cross-protection is long-term.  A study done in 1993 by Nielsen supported this 
concept of cross-protection for live H. parasuis strains.   H. parasuis serovars 2, 3, 
4 and 7 given as a single aerosol gave heterologous protection to serovar 5 
challenge (Nielsen 1993).  It is proposed that intranasal inoculation with a live 
strain induces mucosal antibodies to a spectrum of antigens, including common 
antigens, which result in cross-protection8.  Live intranasal inoculation is practiced 
on some commercial farms in America, where they control expose young piglets to 
all the strains of H. parasuis on the farm.  This concept of controlled exposure has 
been developed in America (Oliveira et al. 2001), it relies on maternal antibodies 
to protect against systemic invasion while the piglet is developing its own 
immunity to the colonising strain of H. parasuis that has been introduced via nasal 
inoculation at 5 days of age to insure all pigs are colonised.  The current project 
has taken this concept of controlled exposure further by only using one of the 
strains on the farm and relying on cross-protection. 
Method 
Preliminary survey 
Serovar profiling was done on a 400 sow farm in Queensland, Australia, where pigs 
displayed symptoms of Glässer’s disease.  Symptoms displayed were coughing, 
anorexia and death in pigs shortly after weaning.  Nasal swabs were taken from 40 
pigs at weaning (three weeks of age) from 10 different sows.  Swabs from the 
nasal cavity were also taken from 7 sick pigs displaying signs of Glässer’s disease.  
A necropsy was also performed on a sick pig.  Amies transport swabs were used to 
swab the nasal cavity.  The collected swabs were kept on ice until they were 
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inoculated on to BA/SN agar.9  Blood agar plates cross-streaked with a nurse 
colony of Staphylococcus hyicus were used as purity control.  Colonies of H. 
parasuis were identified with PCR (Oliveira et al. 2001).  All H. parasuis isolates 
were genotyped with the Enterobacterial repetitive intergenic consensus-based 
(ERIC) PCR (Oliveira et al. 2003) and at least one representative of each genotype 
was serotyped.  Serotyping was done via the gel diffusion and indirect 
haemagglutination assay (Turni and Blackall 2005).  A serovar 6 was chosen as the 
challenge strain. 
Pigs 
In the first trial the control and treatment group consisted of 19 and 21 sows, 
retrospectively.  In the second trial the control and treatment group consisted of 
20 and 22 sows, retrospectively.  All sows were vaccinated twice prior (3 and 5 
weeks prior) to farrowing with an autogenous killed vaccine from the serovar 6 
obtained from the farm in the preliminary survey.  
Bacterial strain 
The serovar 6 H. parasuis strain from the farm serotyped as serovar 6 in the gel 
diffusion but was a serovar NT in the IHA.  The strain was revived from -70°C 
storage three days prior to preparation onto BA/SN agar (Turni and Blackall 2007).  
It was plated onto chocolate agar plates, that consisted of BBLTM Blood Agar Base 
(Becton Dickinson, Sparks, MD USA), 5 % defibrinated sheep blood (Bio-Lab, 
Melbourne VIC) and 0.0025% reduced nicotinamide adenine dinucleotide (NADH) 
(Roche Diagnostics, Mannheim Germany), twice before harvesting after 18 hours 
incubation at 37°C.   H. parasuis was harvested into 2 ml of phosphate buffered 
saline and then diluted to a concentration of 7 x 105 cfu/ml.  A sample of the 
prepared inoculum, as well as samples of the left over inoculum was plated onto 
chocolate agar plates and a count performed after one day incubation.  The 
inoculum was kept on ice until being used for inoculation four hours after 
preparation.  Survival counts after 7 hours showed that the prepared inoculum was 
at the same concentration for this period if kept on ice.  0.5 ml of the inoculum 
was sprayed into each nostril of the pigs.   
Experimental set-up 
The nursery consisted of sow stalls that did not allow for contact between the 
piglets of different sows, as each stall was partitioned off.  In the first experiment 
the control group of sows was in a different shed to the treatment group sows.  In 
the second experiment both sows were in the same shed with the control group 
grouped together and the treatment group in two groups. 
The farm was set up with weaning sheds that consisted of three sections; each 
week one of the sections would be filled with weaned pigs.  For the purpose of the 
experiment the experimental groups where one week apart with he control group 
being the first weaned, followed by the treatment group the following week 
leaving a section between the two groups.  This was done to prevent nose to nose 
contact between the two groups.  The experiment was then repeated. 
Protocol 
First experiment:  The groups consisted of 193 piglets for the control group and 
207 pigs for the treatment group.  207 pigs were controlled exposed at four to 
eight days of age.  Of these piglets 179 pigs for the control and 186 for the 
treatment group were weaned at 21-25 days of age for the control and 19-21 days 
of age for the treatment group.  The freshly prepare inoculum had a concentration 
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of 1.47 x 104 cfu/ml H. parasuis, while the inoculum counted 10 hours after 
preparation had a concentration of 6.7 – 7.4 x 103 cfu/ml H. parasuis. 
Second experiment:  The groups consisted of 199 piglets for the control group and 
217 pigs for the treatment group.  217 pigs were controlled exposed at four to 
eight days of age.  Of these piglets 176 pigs for the control and 193 for the 
treatment group were weaned on two separate days at 21-22 days of age and 21 – 
24 days of age for the control and 21-22 days of age and 21 – 24 days of age for 
the treatment group.  The freshly prepare inoculum had a concentration of 2.85 x 
104 cfu/ml H. parasuis, while the inoculum counted 10 hours after preparation had 
a concentration of 0.7 – 1.47 x 104 cfu/ml H. parasuis. 
Both experiments:  At weaning between 47 and 63 pigs were nasal swabbed to 
serovar profile the groups.  In the first experiment 54 pigs for the control and 47 
pigs for the treatment group were swabbed.  In the second experiment 63 pigs for 
the control and 48 pigs for the treatment group were nasal swabbed at weaning.  
Sick pigs in all groups were sampled twice a week to establish the serovars causing 
disease.  Number of mortalities, number of antibiotic treatments and symptoms of 
disease were recorded throughout the experiment.  Each pig was ear-marked with 
the sow number.  Once the pig was treated it received an ear tag.  At the end of 
the experiment the number of ear tags was recorded.  Some pigs were sampled 
more than once during the experiment. 
Results 
Preliminary survey 
The healthy pigs yielded serovars: 5, 6, 9, 9/13, 10, 15 and NT, while the sick pigs 
yielded serovars: 12, 15 and NT.  Serovar 15 was recovered from the lung tissue of 
the necropsied pig.  From 12% (5) of the 40 healthy pigs sampled at weaning H. 
parasuis was not recovered. 
Experiments 
The data of the experiments is summarised in Tables 1 and 2.  Table 3 represents 
a summary of the sick and dead pigs during the experiments.  Table 4 summarises 
all the serovars found on the farm with the number of genetic profiles for each 
serovar
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Table 1 Data for experiment 1 is represented in this table.  Sampling of sick pigs is recorded with the symptoms and serovar recovered from these pigs.  
The pigs were ear- marked and could be traced back to their mother.  The highlighted fields represent serovars which are potentially pathogenic 
according to literature4 or our experience. 
 
 
group sow
piglets 
tested/so
w serovars
maximum 
serovars/pi
glet
sick at 
weaning 
2/4/07  and 
5/4/07 symptoms serovars
5/4/07 Thur 
(4 days 
post 
weaning) 
not ear 
tagged symptoms serovars
6/4/07      no 
treated /sow -  
symptom - 
antibiotic
13/4/07 Fri 
sampling 
sick eartag 
pigs
symptoms/
treatment serovar
13/4/07 
sampled 
without ear 
tag symptoms serovar
13/4/07      no 
treated /sow -  
symptom - 
antibiotic
17/04/07    
ear tagged 
and not ear 
tagged symptoms serovar
18/4/07      no 
treated /sow -  
symptom - 
antibiotic
25/4/07      no 
treated /sow -  
symptom - 
antibiotic
26/4/07 Thurs 
sampled 
without ear 
tag (got 
Penicillin 
after 
swabbing)
symptoms (all 
got Bomox) serovars
26/4/07   
already ear 
tagged   no 
treated /sow -  
symptom - 
antibiotic
c 1 3 NT  + 9 2 1 cough 9 1 cough, diarrh
c 2 3 9 + 9/13 1 1 cough 9/13
1 - dopey 
Bomox
1 - skinny 
Bomox
c 3 2 9 + 2 1
1 -  crook leg 
Propen 1
swollen hock 
joint 10
c 4 3 NT  + 2 1 1 skinny NT 1 sick NT
2 - skinny 
Bomox 1
backbone 
showing -
Bomox 15 1 skinny 15
c 5 3 9 1
c 6 3 9 + NT 1 1 cough 9
1 small skinny 
Bomox
1 - skinny 
Bomox 1 - Bomox
c 7 2 NT 1
1              1                      
1
skinny          
skinny           
skinny Protease
1 - skinny 
Bomox 1
skinny - 
Bomox NT 1
skinny - 
Bomox NT
1                                        
1
swollen leg
skinny
c 8 3 9 + NT 1 1 skinny 9
2 - skinny, 
scour - 
Bomox + 
Trisoprim 1
skinny - 
Bomox 9 1
skinny - 
Bomox 9
1- bad leg 
Banacillin 
Bomox
c 9 3 9 1
1 - skinny ear 
swollen 
Bomox
c 10 2 NT 1 1 skinny 6 1
heavy 
breathing 6
c 11 3 15 1 1 cough 15
1 - skinny 
Bomox 2
skinny - 
Bomox
15+10                 
15+10
1 - skinny 
Bomox
c 12 3 15 1
1 - skinny 
Bomox
1                   
1
skinny           
cough - 
Bomox
15     5or12
1 cough 13+10
1 - skinny 
Bomox 1 - Bomox
c 13 3 NT + 10 1 1 skinny 10
c 14 3 NT 1 1 diarrh 2/1
c 16 3 NT 1 1 cough NT
c 17 3 NT 1
1  crook leg - 
Propen 15  and 9
c 18 3 NT 1
1 - skinny 
Bomox
c 19 3 10 1
1 - skinny 
backbone 
showing 
Bomox
c 45 3 NT + 11 1
1                             
1
skinny(sick)     
discoord.
NT                   
NT
1                        
1
skinny, 
scour - 
Trisoprim, 
Bomox              
backbone - 
Bomox
15                        
no Hps 1 - skinny 
Bomox  1 - 
skinny, scour 
Bomox 
Trisoprim 1 - Bomox
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group sow
piglets 
tested/so
w serovars
maximum 
serovars/pi
glet
at weaning 
2/4/07  and 
5/4/07 symptoms serovars
5/4/07 Thur 
(4 days 
post 
weaning) 
not ear 
tagged symptoms serovars
6/4/07      no 
treated /sow -  
symptom - 
antibiotic
13/4/07 Fri 
sampling 
sick eartag 
pigs
symptoms/
treatment serovar
13/4/07 
sampled 
without ear 
tag symptoms serovar
13/4/07      no 
treated /sow -  
symptom - 
antibiotic
17/04/07    
ear tagged 
and not ear 
tagged symptoms serovar
18/4/07      no 
treated /sow -  
symptom - 
antibiotic
25/4/07      no 
treated /sow -  
symptom - 
antibiotic
26/4/07 Thurs 
sampled 
without ear 
tag (got 
Penicillin 
after 
swabbing)
symptoms (all 
got Bomox) serovars
26/4/07   
already ear 
tagged   no 
treated /sow -  
symptom - 
antibiotic
t
20 
(wrong
) 1 1/11 1 1 sick 9
1 - skinny 
Bomox 1
small, 
skinny, 
scour, died 
12/4 1 - Bomox
t 21 2 9 + 6 1
1 - skinny, 
scour Bomox 
Trisoprim
1 - skinny 
Bomox    1 - 
skinny + crook 
leg Bomox 3 skinny
10                                           
6                                           
9 + 6
t 22 2 NT 1 1
backbone 
showing 5or12
t 23 2 9 1
1 - cough 
Bomox
t 24 2 10 1 1
cough - 
Bomox 
died? 1
backbone 
showing
1 - skinny  
Bomox
1 - skinny 
Bomox   1 - 
coughing 
Bomox   1 - 
backbone 
showing 
Bomox 1 - Bomox
t 25 2 9 1 1 skinny 9
1 - skinny 
(small) 
Bomox
t 26 3 6 + 9 1
t 27 3 10 + 9 1 1 9 1  9
1 - cough 
Bomox
2 - skinny  
Bomox
1 - backbone 
showing 
Bomox 1 skinny 6
t 28 3 6 + 9 + 10 1 1
skinny - 
Bomox 9+6 1
skinny         
backbone 
showing
1 - skinny little 
Bomox 
t 29 3 6 + 9/13 1
1                                             
1 
cough - 
Bomox       
skinny-
Bomox
no Hps       
9 2 - Bomox
t 30 3 6 + 9 1
1 - cough 
Bomox 1 diarrhoea 9
2 - skinny  
Bomox
t 31 2 10 1 1 coughing 10
t 32 3 9 + 11 1
1 skinny - 
Bomox
t 33 2 6 + 9 1
t 34 2 6 + 9/13 1
1 - backbone 
showing 
Bomox 1 skinny NT 1 - Bomox
t 35 2 6 + 10 1
1 - skinny  
Bomox
t 36 2 9 + ? 1 1 sick 10 1
scour - 
Trisoprim no ?Hps
1 - backbone 
showing 
Bomox 2 skinny 9/10
t 37 2 9 1
t 38 3 6 + 9/13 1 1 skinny 5or12
1 - skinny 
Bomox
1 (tagged)                             
1
skinny         
backbone 
showing
1 - dopey  
Bomox
1 - skinny 
Bomox  1 - 
backbone 
showing 
Bomox 1 skinny 9/10 1 - Bomox
t 39 2 6 1
t 40 3 6 1 1
scour - 
Trisoprim no Hps 1 skinny ?
1 - skinny 
Bomox
2 - skinny  
Bomox
1 - backbone 
showing 
Bomox
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Table 2 Data for experiment 2 is represented in this table.  Sampling of sick pigs is recorded with the symptoms and serovar recovered from these pigs.  
The pigs were ear- marked and could be traced back to their mother.  The highlighted fields represent serovars which are potentially pathogenic 
according to literature4 or our experience. 
 
 
group sow
weaned/ not 
weaned 
(17/5/07)
piglets 
tested/so
w serovars
maximum 
serovars/pi
glet
at weaning 
10/5/07  
and 17/5/07 symptom serovar
22/5/07 Tues 
no 
treated(Fri)/s
ow -  
symptom - 
antibiotic//  
all treated 
today symptom serovar
29/5/07 Tues 
no 
treated(Fri)/s
ow -  
symptom - 
antibiotic/  all 
treated today symptom serovar
29/5/07 no 
ear tag  no 
treated/sow -  
symptom - 
antibiotic/  all 
treated today symptom serovar
5/6/07 Tues 
no 
treated(Fri)/s
ow -  
symptom - 
antibiotic/  
all treated 
today symptom serovar
5/6/07 
healthy pigs 
sampled serovar
8/06/2007 all 
already ear 
tagged pigs 
treated with 
Bomox and 
Trisoprim
C 1 yes 3 9
C 2 yes 3 9(13)
C 3 yes 3 9(13)
C 4 yes 3 10
C 6 yes 3 9
C 7 yes 3 9
C 8 yes 3 9
1 Bomox + 
Trisoprim      1 
Bomox + 
Trisoprim
skinny               
skinny + 
diarrhoea
                          
6             
15+6
C 9 yes 3 9
C 10 yes 1 9
C 11 yes 3 9
1 Bomox + 
Trisoprim skinny no Hps
C 12 yes 3 9
C 13 yes 3 9
1 Bomox + 
Trisoprim skinny no Hps
C 14 yes 3 9 1
swollen 
shoulder joint no Hps
C 15 yes 1 11
C 17 yes 1 9(13)
1 Bomox + 
Trisoprim skinny no Hps
1 Bomox + 
Trisoprim skinny 15
C 18 yes 1
C 19 yes 3 10
C 20 yes 1 9/10
C 19 no 3 9(13)
C 20 no 3 15
C 22
1 Bomox + 
Trisoprim very skinnyskin no Hps
C 9 no 3 9(13)
C 5 no 3 9(13)
1 Bomox + 
Trisoprim skinny no Hps
C 15 no 3 9
C 16 no 3 9
1 Bomox + 
Trisoprim   skinny             9/10
1 Bomox + 
Trisoprim   skinny             6 + 15
C 17 no 3 9(13)
1 Bomox + 
Trisoprim     1 skinny 6
C 18 no 3 9
1 Bomox + 
Trisoprim     1 
Bomox + 
Trisoprim
skinny              
skinny
NT            
6+ 10
C 10 no 1 9(13)
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group sow
weaned/ not 
weaned
piglets 
tested/so
w serovars
maximum 
serovars/pi
glet
at weaning 
10/5/07  
and 17/5/07 symptom serovar
22/5/07 Tues 
no 
treated(Fri)/s
ow -  
symptom - 
antibiotic/  
all treated 
today symptom serovar
29/5/07 Tues 
no 
treated(Fri)/s
ow -  
symptom - 
antibiotic/  all 
treated today symptom serovar
29/5/07 no 
ear tag  no 
treated/sow -  
symptom - 
antibiotic//  
all treated 
today symptom serovar
5/6/07 Tues 
no 
treated(Fri)/s
ow -  
symptom - 
antibiotic/  
all treated 
today symptom serovar
5/6/07 
healthy pigs 
sampled serovar
8/06/2007 all 
already ear 
tagged pigs 
treated with 
Bomox and 
Trisoprim
T 12 yes 1 9(13)
1 Bomox + 
Trisoprim slow no Hps
T 19 yes 1 6
T 20 yes 1 9
1 Bomox + 
Trisoprim skinny 6
T 21 yes 1 6 healthy 5 + 6
T 22 yes 2 9
1 Bomox + 
Trisoprim   
 (only 
slightly) 
skinny no Hps 1 skinny no Hps healthy
T 23 yes 2 9(13)
T 24 yes 2 9(13)
1 Bomox + 
Trisoprim
not really 
skinny no Hps healthy 6
T 25 yes 2 10 1 skinny 10 + NT
1 Bomox + 
Trisoprim      
1 Bomox + 
Trisoprim
skinny                 
skinny + slow
10            
no Hps healthy 6
T 26 yes 2 9 1 skinny no Hps
healthy        
healthy          
healthy  
6               
6                 
6              
T 27 yes 2 10 healthy 10 + 6 + 6
T 29 yes 2 10
healthy              
healthy
no Hps            
6
T 30 yes 2 NT healthy
T 31 yes 2 9
healthy             
healthy    
healthy
9                
no Hps                   
9
T 32 yes 2 NT
1 Bomox + 
Trisoprim coughed Fri no Hps
1 Bomox + 
Trisoprim skinny no Hps healthy
no Hps            
6
T 33 yes 2 6
T 34 yes 2 NT
T 35 yes 3 6 1 cough 13
T 36 yes 3 6
T 37 yes 2 13
T 40 yes 2 9
T 38 no 2 9(13)
T 39 no 2 9(13) healthy no Hps
T 40 no 2 9(13)
T 41 no 2 6
1 Bomox + 
Trisoprim 
treated due to 
skinny today 
diarrhoea healthy no Hps
T 42 no 2 9(13)
T 43 no 2 9(13)
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Table 3 This is a summary of the numbers of pigs born, death during farrowing, total 
numbers weaned, numbers tested at weaning and total numbers treated for both 
experiments. 
 
 
 
Table 4  All serovars present on the farm together with the numbers of genotype per 
serovar are recorded in this table. 
 
 
 
Discussion 
This farm is certainly exceptional in regards to the number of serovars of H. 
parasuis found on the farm.   When serovar profiling farms over the years we have 
encountered one farm that had six serovars, but most had from one to five serovars 
with an average of three serovars per farm.  The preliminary sampling on this farm 
only yielded 8 serovars, while further sampling in the experiments yielded a total 
of 14 serovars. 
In the first trial we did not recover H. parasuis from 1.9% of control group and 2.1% 
of treatment group sampled.   In the second experiment H. parasuis was not 
recovered from 8.7% of control and 4% of the treatment group.  These percentages 
are lower than was seen in the preliminary sampling where 12% of the samples did 
not yield H. parasuis. 
If the principle of cross-protection of a live strain of H. parasuis works, this would 
mean that the total number of pigs getting sick with H. parasuis should reflect the 
percentage of pigs that are naïve (not colonized) at weaning.  This is certainly not 
the case for the first experiment.  Antibiotic treatment was given to 8.4% of the 
control group pigs and 14% of the treatment group pigs in the first experiment (that 
is assuming that they had to be treated due to Glässer’s disease).  In the second 
Age (days) at 
weaning
Total 
number 
weaned
Total no 
born overlay broken leg
non 
viables malnutrition
Total pigs 
tested at 
weaning
N of 
tested with 
Hps
Total no 
treated
first experiment weaned on one day
Control group (c) 21-25 179 193 10 1 3 54 53 15
Treatment gorup (t) 19-21 186 207 18 3 48 47 26
second experiment
weaned on 
two days 
(Thurs+Mo)
Control group (c) 21-22, 21-24 176 199 13 7 3 69 63 16
Treatment gorup (t) 21-22, 21-24 193 217 13 10 1 50 48 10
Death in farrowing shed due to:
Serovars Genotypes
1/11 1
2
2/1
6 2
9 4
9/10 1
9/13 1
10 1
11 1
15 2
5
12
13 1
NT 2
14 18
1
1
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experiment the percent of pigs getting sick (9.1% for control group and 5.2% for the 
treatment group) was close to the number of naïve pigs in the two groups.  The 
problem with executing experiments on a farm is that other factors will affect the 
experiment and such a factor might be co-infection and environmental factors.  As 
no necropsies were done on any of the pigs, the symptoms these sick pigs displayed 
can not be linked definitely to H. parasuis infection or other diseases. 
When sampling at weaning in both experiments, it is noticeable that serovar 6 was 
found only in the treatment group.  It is not obtained from all treatment animals 
sampled, but pigs can have more than one serovar of H. parasuis in their nasal 
cavity.  This finding of serovar 6 only being retrieved from samples of the 
treatment group suggest that the controlled challenge has established colonization 
of the strain. 
When comparing the serovar profile of the two experiments it can be seen that the 
profile changed.  In the second experiment the serovar 9 and 9(13) became much 
more dominant, especially in the control group.  Serovar 2 and 1/11 from trial one 
were not seen in trial two.  The serovar 13 in the second trial was not encountered 
in the first trial.  This would suggest that these serovars are not very dominant and 
are only present in a small number of sows. 
H. parasuis is a problem on most farms about 7 - 14 days after weaning.  This farm 
seems no exception to this.  In the preliminary sampling 12, 15 and NT were 
sampled from sick picks, with the necropsy yielding serovar 15.   Experience with 
serovar profiling farms has indicated that if there is a problem with H. parasuis on 
a farm then sampling sick pigs seems to yield pathogenic strains as is seen in the 
preliminary sampling of this farm (12 and 15 are pathogenic strains, pathogenicity 
for NT is not known).  Seeing that serovar 15 was obtained from a necropsy sample 
it can be assumed that this serovar is causing problems on the farm.  The 
interesting observation in both experiments is that sampling sick pigs from the 
control group yields serovar 15, while none of the sick pigs from the treatment 
group yields this serovar.  Especially in the second trial, it becomes apparent that 
the sick pigs in the treatment group do not yield H. parasuis after weaning and if 
then it is the serovar distributed by the sow.  In the first trial a lot more pigs of the 
treatment group were treated with antibiotics than in the control group (26 verses 
15).  However, 11 days after weaning, the time when serovar 15 became apparent 
in the control group, most of the sick pigs of the treatment group had serovars that 
were non-pathogenic.  The pathogenic serovars were only displayed 20 days past 
weaning, but except of the serovar 9/10, the other serovars were seen at weaning.  
It might be that these pigs at 20 days past weaning had other problems than H. 
parasuis.  
This trial gives some indication that controlled exposure has the potential to work, 
but the concept needs to be proven on a farm that has an acute problem with H. 
parasuis and were most of the pigs are not colonized with a strain of H. parasuis. 
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Appendix 3 - Preliminary Trial – Farm 4 
 
Method 
A total of 13 sows were vaccinated 5 and 3 weeks before farrowing with a 
Haemophilus parasuis serovar 9 strain from the farm .  This is a non-pathogenic 
serovar based on literature reports.  The outbreaks of Glässer’s disease on this 
farm in the past have been associated with a H. parasuis isolate that shows a 
serovar 1/11 cross-reaction.  The sows in this trial were split into two groups at 
farrowing.  Seven sows were allocated to the treatment group and six sows 
allocated to the control group.  The piglets of the sows from the treatment group 
were given a controlled exposure of the serovar 9 strain (2.4 – 2.8 x 105 colony 
forming units per pig) at 5 days of age.  There were a total of 71 piglets in the 
treatment group (given the controlled exposure) and a total of 63 pigs in the 
control group (not given a controlled exposure).     
Two days before weaning 31 pigs of the treatment group and 29 pigs of the control 
group were nasal swabbed. 
At weaning (21 days of age) both groups were sent into the same igloo but in 
opposite pens.  The treatment group pigs were in the pen with all the male pigs 
and the control group pigs were in the pen with the female pigs.  A total of 425 
pigs were weaned into that igloo (across both pens) on the day.  The other pigs in 
the igloo were given Draxxin and an inactivated Glässer’s disease vaccine that 
contained the pathogenic strains from the farm but not the serovar 9 strain, at 
weaning. 
Eight days after weaning, one pig from the treatment group and three from the 
control group were sampled via nasal swabbing.  These pigs were selected due to 
“hollow” looking appearance.  On that day, the second phase food was introduced 
which contained Amoxicillin.  Ten days after weaning only second phase food was 
fed. 
Eleven days after weaning, nasal swabs were taken from 39 treatment pigs and 
52 control pigs.  On that day, Amoxicillin was added to the water, with the 
Amoxicillin being added daily for 5 days. 
Thirteen days after weaning, nasal swabs of another 6 treatment pigs were 
collected. 
At 14 days after weaning, one treatment pig was shifted to the sick pen. 
At 18 days post weaning, Amoxicillin was again added to the water (it had not been 
present for the previous two days).  A nasal swab from one treatment pig was 
collected on that day. 
At 25 days after weaning, the pigs were shifted into another igloo. 
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Results 
Table 1.  Detailed results and observations 
Date  Groups/ observations Result of swabbing 
19 days of 
age 
nasal swabbed 29 control group  pigs and 31 
treatment group pigs 
retrieved serovar 9 from one 
pig from control group 
5 days after 
weaning 
all pigs looked fine  
8 days after 
weaning 
sampled 4 pigs: 
Treatment group - one hollow looking 
Control group: two hollow looking and one 
hollow and skin a bit scruffy looking 
Control group: one scruffy 
pig and one hollow pig - 
serovar 1/11 
third pig - serovar 9 
11 days 
after 
weaning 
all pigs had fallen back, looked tugged in, no 
coughing 
swabbed 52 control group pigs and 39 treatment 
group pigs. 
Classed pigs according to good, average and 
poor condition                                                          
Control group: 28 good, 13 average and 11 poor  
(54, 25 and 21%)                                                          
Treatment group: 20 good, 14 average and 5 
poor (51, 36 and 13%)                                                   
took 4 worst control group pigs (6.3%) into the 
nursery 
Control group: 25 pigs (48%) 
had serovar 1/11, 24 pigs 
(46%) no Hps, 2 pigs had 
serovar 9 and 1 pig ? 
 
Challenge group: 27 pigs 
(69%) had serovar 1/11 and 
12 pigs (31%) no Hps 
13 days 
after 
weaning 
pigs looked much better and even the four in 
the nursery, which did not get extra antibiotics 
except Amoxicillin in feed, looked much better 
 
sampled 6 treatment group pigs, two coughed, 
two looked a bit scruffy and two healthy 
Hps serovar 1/11 from two 
coughing pigs and from one 
scruffy pig 
14 days past 
weaning 
one treatment group pig taken to sick pen -  too 
skinny  
15 days 
after 
weaning 
pigs looked same as two days before                                          
pig in sick pen did get milk and Amoxicillin and 
had improved 
 
18 days 
after 
weaning 
all pigs looked fine, even the ones in the 
nursery and sick pen                                                              
one treatment group pig was very small and was 
sampled 
Hps serovar 1/11 from small 
pig 
21 days 
after 
weaning 
pigs from nursery had been returned to igloo 19 
days past weaning, 
small pig, which was sampled at 18 days,  was 
taken to sick pen 
 
 
No trends were observed between sickness of piglets and sow number. 
The control pigs were as sick as the rest of the pigs in the igloo.   One observation 
was that of all the other pigs in the igloo, the male pigs looked more affected by 
the disease than the female pigs. 
Out of 425 pigs in the igloo one pig died and 15 pigs (3.5%) were pulled out.  
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Summary 
As these two groups of pigs were in a large igloo with other pigs, all pigs had to be 
treated when pigs were falling back in health.  The strain that causes disease on 
the farm is very pathogenic and treatment has to be given early, otherwise pigs do 
not recover.  Despite being on antibiotics and having being given a conventional 
killed vaccine, the pigs not in the control or treatment groups were also falling 
back, and needed treatment on day 11. 
The aim of this experiment was to establish whether the number of sick pigs and 
the mortality rate in the control group would not exceed the death rate observed 
previously on farm.  It was also meant to establish the safety of the controlled 
exposure method.   
None of the pigs in the experiment died.  The four pigs taken out into the nursery 
where taken out to avoid the treatment of antibiotics which had to be given to all 
pigs in the igloo via the water.  These pigs did not get the antibiotic in the feed.  
Therefore, the number of sick pigs taken out was only slightly higher due to our 
artificial intervention (6.3% compared to 3.5%).  
In summary, the experiment established that the death rate and the number of sick 
pigs would not increase in pigs that are not given the vaccine used for the farm and 
the antibiotics used at weaning.   
The management of the farm has agreed to allow further experiments on the farm. 
The treatment group had 13% poor pigs when pigs were classed compared to 21% in 
the control group.  However, there were more average looking pigs in the 
treatment group.   
One observation that would indicate that the controlled challenge dose is too low 
is the fact that H. parasuis was not recovered from the nasal cavity of the 
treatment pigs two days before weaning.  Therefore, the next step is to establish a 
challenge dose at which all treated pigs get colonised. 
 
  37 
Appendix 4 - Dosage Trial – Farm 4 
Background 
During the preliminary trial to test the safety of controlled exposure of 
Haemophilus parasuis, it was discovered that, at weaning, the particular strain 
used for the controlled exposure –a serovar 9 strain– –given as a controlled 
exposure (at 5 days of age) in the nostrils of the exposed pigs could not be 
retrieved from the nasal cavity at weaning.  As this could suggest that the dosage 
rate for the controlled exposure was too low, a titration of higher dosage levels 
was used to establish whether higher concentration of the controlled challenge 
inoculum could be retrieved back when sampled just before weaning. 
Method 
Experiment 
Eight sows were vaccinated with an autogenous, killed vaccine twice before 
farrowing (three and five weeks prior to farrowing).  The autogenous vaccine 
contained the serovar 9 strain, which was used for the controlled challenge of the 
sows’ piglets.  There were four dosages used (expressed as organisms given per 
piglet) were: - 1,000,000 organisms, 10,000,000 organisms, 100,000,000 organisms 
and 1,000,000,000.  The four groups of sows and their litters were well separated 
by space and had no opportunity to have contact with each other.  The sows used 
in the experiment were low parity sows, as young sows are most likely not to be 
colonised with Haemophilus parasuis. 
The piglets were controlled exposed at 6 – 7 days after birth and ear tagged on the 
day.  No antibiotics were administered for a week after challenge.  One day before 
weaning (20 days of age) all the pigs were nasal swabbed to check for colonisation.  
The pigs were then weaned into two pens in the same eco-shelter.  They were 
separated by sex into these two pens.  The eco-shelter holds a total of 400 pigs.  At 
10 days after weaning a total of 64 pigs from the groups were nasal swabbed.  An 
additional 40 pigs from the other animals (not tagged) in the pens were nasal 
swabbed (20 female and 20 male). 
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Table 1.  Details of pigs and sampling regime 
Ear tag (dosage) Sow number Males  Females  Total  
Controlled exposed 
Red ( 106 cfu/ml) U46672   11 
Red ( 106 cfu/ml) U4672   11 
Purple ( 107 cfu/ml) U4689   10 
Purple ( 107 cfu/ml) U4687   10 
Blue ( 108 cfu/ml) U4654   10 
Blue ( 108 cfu/ml) U46683   10 
White ( 109 cfu/ml) U4671   11 
White ( 109 cfu/ml) U4703   12 
Sampled one day before weaning 
Red ( 106 cfu/ml) U46672   10 
Red ( 106 cfu/ml) U4672   11 
Purple ( 107 cfu/ml) U4689   10 
Purple ( 107 cfu/ml) U4687   10 
Blue ( 108 cfu/ml) U4654   10 
Blue ( 108 cfu/ml) U46683   10 
White ( 109 cfu/ml) U4671   11 
White ( 109 cfu/ml) U4703   11 
Sampled 10 days after weaning 
Red ( 106 cfu/ml)  8 9 17 
Purple ( 107 cfu/ml)  5 10 15 
Blue ( 108 cfu/ml)  13 3 16 
White ( 109 cfu/ml)  5 11 16 
 
Not tagged  20 20 40 
 
Dosage of controlled exposure 
H. parasuis HS2991 (serovar 9) was revived from storage four days prior to the 
controlled exposure.  The strain was plated onto BA/SN agar and blood agar as 
purity control.  After 24 hours at 37°C, the strain was plated onto BA/SN plates.  
After another 24 hours, the strain was plated onto 50 BA/SN plates.  After 
overnight incubation, the BA/SN plates were used to inoculate 100 chocolate agar 
plates plus 50 purity control plates which were then incubated for 18 hours.  The 
plates were then harvested to make the four dosages of controlled challenge. 
106  -Two chocolate agar plates were harvested into 6 ml PBS.  A 1,000 µl aliquot of 
this dilution was added to 4 ml of PBS.  From this another 1,000 µl was diluted into 
4 ml PBS and that was then added to 46 ml PBS.  Prior experiments have shown 
that this should have yielded 106 cfu/ml. 
107 - Two chocolate agar plates were harvested into 12 ml PBS.  Ten ml of this 
dilution were added to 40 ml PBS. This should have yielded 107 cfu/ml. 
108 - Four plates were harvested into 24 ml of PBS.  This was repeated and both 
dilutions combined.  This should have yielded 108 cfu/ml. 
109 - Ten chocolate agar plates were harvested into 12 ml of PBS.  This step was 
repeated twice more and all dilutions combined into one bottle.  This should have 
yielded 109 cfu/ml. 
All dosages were done in duplicate. 
The final dilution for each dosage level was counted by transferring 1,000 µl of the 
final dilution into 9 ml PBS and doing serial dilutions.  A 100 µl aliquot of the 
relevant dilutions expected to contain 104, 103 and 102 cfu/ml from each dosage 
level were spread onto BA/SN plates and incubated overnight for counting the next 
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day.  Upon arrival back from the farm the remaining control challenge inocula, 
which had been kept on ice were counted. 
Inoculation 
Each pig was given 0.5 ml of the relevant inoculum into each nostril.  Piglets with 
the lowest dosage were done first followed by piglets with progressively higher 
dosages. 
Results 
Table 2.  Actual doses (expressed as cfu/ml) at preparation and after vaccination 
 Predicted Dose 
Preparation 106 107 108 109 
Count before 
vaccination ~3.6 x 108 4.3 x 107 3.7 x 108 1.08 x 109 
Count after 
vaccination (9 
hours after 
harvest) 
5.1 x 106 3.2 x 107 0.9 x 108 0.6 x 109 
 
Sampling at one day before weaning 
H. parasuis was recovered from two piglets, which were both from sow U4654.  
They had been given a dosage of 108 cfu/ml.  This means that just two animals out 
of the 83 animals sampled yielded H. parasuis.  The serovar recovered from both 
animals was serovar 9 (the same as given in the controlled exposure and which is 
also present on the farm).   
Sampling 10 days after weaning 
Out of the 64 controlled exposed animals sampled, H. parasuis was recovered from 
one pig, which had been challenged with 106 cfu/ml.  The serovar recovered was 
serovar 9. 
Out of the control animals three animals yielded H. parasuis.  Two of them had 
serovar 9, while the third had serovar 1/11. 
Discussion 
The dosage level did not seem to make a difference in the recovery of H. parasuis 
from the nasal cavity.  The low levels at which H. parasuis was recovered in the 
controlled exposured pigs matched the normal low level of serovar 9 which has 
been found previously on the farm.  As an example, in the preliminary experiment 
two pigs out of 52 control pigs were colonised with serovar 9, which is a prevalence 
of 3.8%. 
As the inoculum of H. parasuis was still viable upon return to the laboratory, the 
assumption can be made that there was nothing wrong with the inoculum.  Every 
precaution was taken not to negatively affect colonisation, including preventing 
antibiotic treatment for 7 days after the controlled challenge. 
The technique of nasal swabbing only samples the bacteria in the upper part of the 
nasal cavity.  It is possible that the bacteria sprayed into the nasal cavity do not 
colonise in this part of the nasal cavity.  It might establish in the lower part of the 
nasal cavity or in the tonsils and even trachea. 
The low prevalence of serovar 1/11 in the control pigs, which should, but did not, 
at day 10 after weaning come down with Glässer’s disease is noteworthy.  In the 
preliminary trial 25 pigs out of 52 control pigs had serovar 1/11, which is a 
prevalence of 48%.   
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On the farm there are now sows coming through that have been vaccinated twice 
again since the strain was left out of the vaccine and caused the outbreak of 
Glässer’s disease on the farm.  According to the veterinarian of the farm the 
disease might now be under control.  The animals did not look like they had fallen 
back, as seen in the preliminary trial. 
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Appendix 5 - Serovar profiling of Haemophilus parasuis 
on Australian farms by sampling live pigs 
Introduction 
Haemophilus parasuis, the causative agent of Glässer’s disease, is one of the early 
colonizers of the nasal mucosa of piglets. 1,2  It can be isolated from the nasal 
cavity, tonsils and trachea of pigs via swabs from H. parasuis challenged pigs 
(Oliveira and Pijoan 2004; Kirkwood et al. 2001; Vahle et al. 1997).  For isolation of 
disease causing strains on farms it is usually not recommended to swab from the 
nasal cavity, as the strains of H. parasuis found in the nasal cavity are not 
necessarily the strains that cause disease (Oliveira and Pijoan 2002).  Apparently 
non-pathogenic isolates of H. parasuis have a high prevalence in the nasal cavity, 
while pathogenic isolates have a low prevalence(Oliveira and Pijoan 2002).  The 
usual recommendation for isolation of disease causing organisms is to obtain 
samples from tissues (heart, brain) or fluids (peritoneal, pleural, pericardial, joint) 
collected at necropsy (Oliveira and Pijoan 2002; Oliveira 2004; Turni and Blackall 
2007).  This is an expensive and not always successful exercise and multiple 
isolates still have to be serotyped in case there are multiple serovars present 
(Oliveira and Pijoan 2002). 
A study by Kirkwood et al. (2001) found that litters from multiparous sows had a 
higher level of colonisation with H. parasuis than litters from young sows 
(primiparous).  When comparing weaning at two and four weeks it became 
apparent that the longer period with their mother increased the colonisation levels 
of the litter (Cegielski et al. 1999).  These findings suggest that swabbing weaned 
pigs from multiporous sows (with weaning occurring at 3 weeks of age) should 
optimize the recovery rate.  As pigs suffering from Glässer’s disease have the 
disease causing strain in their nasal cavity (Turni and Blackall 2007) sampling sick 
pigs might enhance the detection of pathogenic strains on the farm.  This paper 
reports on our evaluation of the ability of nasal swabbing to create a profile of the 
H. parasuis serovars present on farms. 
Rafiee at al. (2000) evaluated the enterobacterial repetitive intergenic consensus-
based (ERIC) PCR as a finger-printing tool for H. parasuis strains and concluded that 
each of the 15 reference strains gave a unique ERIC PCR finger-print, which was 
reproducible and stable on repeated tests.  This reproducibility was also noted for 
field isolates.  A study by Oliveira et al. (2003) in which 98 H. parasuis isolates 
from 15 North American herds and multi-farm systems were genotyped by the ERIC 
PCR and then serotyped via gel precipitation concluded that the genotype of an 
isolate is a good predictor of the serovar group with a few exceptions where some 
strains with a similar genomic fingerprint belonged to different serovars.  It was 
not clear whether these exceptions were a real effect or due to incorrect 
serotyping.  In the current study the ERIC PCR was used to genotype isolates and 
the interpretation standard according to Oliveira (2007) was used. 
Method 
The data for this paper was collated from work done A) to find a farm free of 
H. parasuis, B) to screen farms for suitability for Glässer’s disease vaccine trials 
and C) to establish the serovars present on farms for diagnostic and disease control 
purposes.  A total of 13 farms (seven in Queensland, one in New South Wales and 
five in South Australia) were initially sampled over a period of a year. The data was 
then assessed and a further seven farms were sampled.  Except for two farms that 
never had an outbreak of Glässer’s disease (farm 1 and 2), the remaining farms 
involved in this study either had previous Glässer’s disease outbreaks or were 
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suspected of having Glässer’s disease on their farm.  Two farms had a previous 
diagnosed history of Glässer’s disease associated with a known serovar (Farms 3 
and 7 (Table 1)).  The objective of sampling on these farms was to profile the 
serovars of H. parasuis on the farms. 
Three farms were sampled more than once (Farm 3, 10 and 13).  This occurred as 
these farms were involved in either experimental vaccine trials (Farm 3) or 
investigations to monitor the efficacy of conventional autogenous vaccination 
programs.  On Farm 3 twenty-three pigs (from 5 sows) were sampled over the 
period of 14 days to 72 days of age. 
Nasal swabs were either taken from pigs from multiparous sows at weaning time or 
from sick pigs displaying symptoms typically seen in Glässer’s disease (e.g. 
coughing, anorexia) (Turni and Blackall 2007).  The sample sizes varied as it 
depended on the number of multiparous sows available on the day and on the 
number of sick pigs that had signs that were possible associated with Glässer’s 
disease (Table 1).  There was also an upper limit of 50 swabs that could be handled 
in the laboratory.  From Farm 12, a high health farm, we received only 4 swabs yet 
12 pigs were sampled (Table 1).  This farm has a connection with Farms 10 and 11 
and samples were sent in to determine whether the prevalent serovar on the other 
farms was also present on this farm. 
Necropsies were performed on some farms at the same time as sampling was done.  
Specifically, necropsies were performed on one pig (Farms 9, 10 and 11), two pigs 
(Farm 20), three pigs ( Farm 13), five pigs (Farm 14 and 17), eight pigs (Farm 16) 
and ten pigs (Farm 15).  The pigs necropsied were extremely sick pigs displaying 
symptoms typically seen in Glässer’s disease.  Swabs of tissue or tissue blocks were 
taken and sent to the laboratory.  Swabs of the tissue samples were taken at the 
laboratory and all swabs were then processed as detailed below.   
Sick animals for sampling were selected on the basis of showing clinical signs and 
there was no attempt made to definitely establish the cause of the clinical signs.  
The necropsy samples came from different animals than the swabs from sick pigs, 
except on Farms 15 and 16.  Nasal swabs were taken from three or 10 pigs (Farms 
16 and 15 respectively) from which lung samples were also taken at necropsy. 
Swabs were placed in Amies transport media and kept on ice until inoculated on to 
BA/SN agar, prepared as previously described (Turni and Blackall 2007), and on to 
blood agar, the latter being cross-streaked with a nurse colony of Staphylococcus 
hyicus.  The plates were then incubated aerobically for 18 - 24 hours at 37ºC.  
Suspect colonies of H. parasuis were selected and sub-cultured on BA/SN for DNA 
processing, storage and serotyping. 
On most farms only one to two typical H. parasuis-like colonies were examined per 
pig.  On Farm 3 at age 43 days up to 4 colonies and at age 72 days up to six 
colonies were prepared per pig with a total of 34 and 103 isolates, respectively, 
genotyped.  As well, additional colonies were examined on Farms 9 (up to four 
colonies), 10 (up to three colonies) and 11 (two colonies).  Colonies were prepared 
for PCR as previously described (Turni and Blackall 2007)  Isolates were confirmed 
as H. parasuis by the PCR of Oliveira et al. (2001)  ERIC PCR, as described by 
Oliveira et al. (2003) was used to group the strains within one farm according to 
genotype profile.  A total of 556 isolates were genotyped.  The genotype profile 
was compared only within each farm and the interpretation standard according to 
Oliveira (2003) was used.  If two isolates had the same genomic fingerprint, i.e. an 
identical band pattern including location and intensity, they were assumed to be 
the same strain.  For multiple sampling on a farm the known strains were run as 
controls in the ERIC PCR.  If only small numbers of H. parasuis were being 
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compared and the differences were quite obvious, then gels were analysed by eye.  
Otherwise the Bionumercis software (Bionumeric version 4.50, Applied Maths Inc, 
Sint-Martens-Latem, Belgium) was used to analyse the gels.  Within each genotype 
representative isolate/s was/were serotyped by gel diffusion (GD) testing (Turni 
and Blackall 2005).  If a clear cut answer could not be obtained, the isolates were 
then examined by the indirect haemagglutination (IHA) test (Turni and Blackall 
2005).  Isolates which did not react in any of the tests were regarded as non-
typable and were termed serovar NT. 
The pathogenicity of the serovars was according to the classification of Kielstein 
and Rapp-Gabrielson (1992)  with serovars 1, 5, 12, 13 and 14 being highly 
pathogenic, serovars 2, 4 and 15 being moderately pathogenic, serovar 8 being 
slightly pathogenic and serovars 3, 6, 7, 9 and 11 being non-pathogenic. 
Results 
Overall, a total of 556 isolates of H. parasuis were genotyped – with 150 isolates 
being serotyped. 
Of the 20 farms studied, only one farm (Farm 20) failed to yield any isolates of 
H. parasuis.  On this farm, nasal sampling was performed on 15 sick pigs.  Necropsy 
of two pigs on Farm 20 also failed to yield H. parasuis – although Actinobacillus 
pleuropneumoniae was recovered from the lung of one pig. 
On the two farms with an extensive history of freedom from Glässer’s disease 
(Farms 1 and 2), H. parasuis of serovars 6 and NT were found in the nasal cavity of 
weaned pigs (serovar NT on Farm 1 and serovars 6 and NT on Farm 2).  However, 
the colonisation rate was very low (6.7 and 12.5%). 
The initial sampling from Farm 3 of 52 pigs yielded serovar NT but not serovar 4, 
which had caused an outbreak in the past on this farm.  Sampling one sick pig in 
the weaning shed at a later stage yielded a serovar 4 isolate with the same genetic 
profile as the disease causing strain collected when the outbreak occurred (Table 
1).  Subsequent sequential sampling (14, 20, 27, 34, 43 and 72 days of age) of a 
group of pigs over time revealed that this naïve group of pigs remained apparently 
free of H. parasuis until shortly after entering the weaner room (at 34 days of age 
13 out of 23 pigs yielded H. parasuis).  A week after being sent to the weaner 
room, all sampled pigs in the weaner room (two pigs had been held back) were 
colonised by H. parasuis (21 pigs in the weaner room sampled).  At this sampling 
the NT serovar was the only serovar recovered.  At 72 days of age up to six colonies 
of suspect H. parasuis were picked from each of the inoculated BA/SN plate of all 
23 pigs.  A total of 103 isolates of H. parasuis were compared using the genetic 
profile as generated by ERIC PCR.  All 23 pigs were shown to harbour serovar NT 
while six of the pigs had a serovar 4 with these isolates having the same ERIC PCR 
profile as the strain associated with disease on this farm. 
Sampling on Farms 7 and 13 established that sampling healthy weaned pigs does 
not necessarily reveal all serovars associated with disease on the farm (Table 2).  
The serovar 12 found during necropsy at an earlier time than the sampling was not 
found in any of the healthy pigs sampled on Farm 7.  The serovar 4 found at 
necropsy was not found in any healthy pigs sampled from farm 13. In contrast, 
sampling sick pigs seems to increase the chance of obtaining pathogenic serovars, 
as no sick pig from the first 13 farms in this study yielded an isolate of H. parasuis 
of a serovar regarded as non-pathogenic.  This is demonstrated on Farms 10 and 11 
where only sick pigs were sampled and known non-pathogenic strains (like serovars 
3, 6, 7, 9 and 11) were not found.  However, the farms sampled following 
evaluation of the method on the first 13 farms yielded 2 to 9 sick pigs with a non-
pathogenic serovar (Table 2).  On Farm 14 two pigs yielded serovar 6, on Farm 16 
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eight pigs yielded serovar 7 and one pig serovar 9, on Farm 17 two pigs yielded 
serovar 9 and on Farm 19 three pigs yielded serovar 9.  
The result on Farm 9 where two potentially pathogenic serovars (serovars 5 and 10) 
were found only in the healthy pigs and not in the sick pigs suggests that sampling 
healthy pigs is still capable of revealing the presence of potentially pathogenic 
serovars on a farm (Table 2). 
The multiplicity of serovars especially on Farm 9, where a total of eight serovars 
were detected, is noteworthy.  This multiplicity was also seen on Farm 15 with six 
serovars.   Most of the other farms had at least two serovars.  The number of 
serovars recovered varied from one (Farms 1 and 12), two (Farms 2, 3 and 11), 
three (Farms 4, 5, 7, 8, 10 and 17), four (Farms 6 and 18), five (Farms 13, 14, 16 
and 19), six (Farm 15) and eight (Farm 9). 
Farm 12, a high health farm, has a connection with Farms 10 and 11 (Table 1).  The 
farm management wanted to know whether the serovar NT found on Farms 10 and 
11 was also on Farm 12.  A total of 12 pigs, ranging in age from two to four weeks, 
were sampled with four swabs being used across the 12 pigs.  One of the four swabs 
yielded H. parasuis of serovar NT, with this isolate having the same genotype as the 
NT strain on the two other farms (Table 1).   
Farm 13 again showed sampling both healthy and sick pigs gives a better chance of 
finding more serovars on a farm.  The genetic profile of the serovar found in the 
lung samples on this farm was different than the serovar 4 found in the nasal cavity 
of sick pigs at the initial sampling (Table 2).  Therefore not all the genotypes 
present on the farm were found in the initial sampling.  The vaccine strain was 
found in one sick pig only.  A second sampling on Farm 10, after the vaccination 
program with the NT serovar was started, revealed only serovar 4 for one group.  
This was not a dominant strain previously. 
Table 3 shows that occasionally more than one genotype is present for one serovar 
(Farms 9, 10, 11, 13, 15, 16 and 19).  The serovars are not distributed evenly, even 
on farms where only sick pigs were sampled, as on Farms 10, 11, 16 and 19. 
The success rate of isolation of H. parasuis from the nasal cavity was higher than 
from lungs on Farms 15 and 16.  On Farm 15 H. parasuis was recovered from the 
nasal swabs of six out of 10 pigs, while only three lung samples yielded H. parasuis.  
On Farm 16 two out of three nasal swabs yielded H. parasuis while the lungs did 
not yield any H. parasuis.  It is worth noting that the serovars of isolates from the 
nasal cavity and lung of the same pig did not always match up.  On Farm 15, the 
lung sample of pig 1 yielded serovar 4 , while the nasal swab yielded two genotypes 
of serovar 4 (one the same genotype as the lung sample).  In other examples, pig 6 
yielded serovars 4 and 5 from the lung, but serovar 4/6 from the nasal swab, while 
pig 10 had serovar 4 in the lung but no H. parasuis could be retrieved from the 
nasal swab.  The other four animals from Farm 15 yielded H. parasuis from their 
nasal cavity but not their lung. 
Discussion 
H. parasuis is part of the natural flora of the upper respiratory tract of pigs 
(Nedbalcova et al. 2006) so it is not surprising that H. parasuis was found in the 
nasal cavity of weaned pigs on two farms with an extensive history of freedom from 
Glässer’s disease.  According to Kielstein and Rapp-Gabrielson (1992) serovar 6, the 
serovar found on these two farms, is a non-pathogenic serovar.  It would appear 
that the non-typable (NT) serovars found on these two farms without outbreaks 
were also non-pathogenic as the prevalence of these strains was very low and these 
farms have been free of Glässer’s disease outbreaks.  Further sampling of both 
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healthy and sick pigs would be required before any conclusions can be reached on 
whether Farm 20 is truly free of H. parasuis, as only sick pigs were sampled on this 
farm. 
The NT strain found on Farm 3 was assumed to be non-pathogenic, as it spread so 
rapidly without causing any symptoms of disease in the naïve pigs.  The low 
prevalence of the pathogenic serovar 4 strain on Farm 3 matches the finding of 
other researchers of the low prevalence of pathogenic strains (Oliveira and Pijoan 
2002).  The large sample size needed to find this low prevalence strain indicates 
that multiple serovars may not easily be detected if one strain is more prevalent 
than the others.  Clearly, the question arises of how many colonies have to be 
sampled to find strains circulating at a low prevalence.  The result of the current 
study, that many isolates of H. parasuis can be obtained from a given herd, but in 
most cases only one or two strains predominate, coincides with the finding of 
Smart et al. (1988).  Except for a few limited studies, such as on the colonisation 
rate of weaned pigs (Kirkwood et al. 2001; Cegielski et al. 1999), and attempts to 
determining the prevalent serovars in pigs (Kirkwood et al. 2001; Smart et al. 1988; 
Olvera et al. 2006), there is no actual study looking at the diversity within the 
single pig on several farms (on farms with more than two serovars) and the 
prevalence of strains over time.  Therefore, there is no guidance as to how many 
samples have to be taken to establish the serovars present in a pig, especially if 
one strain is dominant. 
Not all pathogenic serovars on a farm were detected when only healthy weaned 
pigs were sampled.  On Farm 7 serovar 12, a highly pathogenic serovar, was found 
from an earlier necropsy sample but not detected in any of the 30 nasal swab 
samples.  This serovar 12 strain was particularly hard to grow and might have easily 
been missed in nasal swabs due to its poor growth.  The difference in growth 
characteristics of various strains has been observed by others (Smart et al. 1988) 
and it has been suggested that some strains could be missed due to this 
heterogeneity(Smart et al. 1988). 
Sampling sick pigs which showed clinical signs suggestive of Glässer’s disease 
yielded only strains of serovars regarded as pathogenic and serovar NT when the 
first 13 farms were evaluated.  Despite the dominant serovar NT strain on Farm 3, 
the pathogenic serovar 4 strain on this farm was recovered effortlessly in the nasal 
cavity of a sick pig (only one colony was collected).  These results, combined with 
the fact that pathogenic strains of H. parasuis given in artificial challenges can be 
found in the nasal cavity (Oliveira and Pijoan 2004; Segales et al. 1997) suggest 
that there is definitely a correlation between sick pigs and the presence of 
pathogenic serovars of H. parasuis in the nasal cavity.  Overall, it seems that 
strains of H. parasuis of known pathogenic serovars can be found in the nasal cavity 
of sick pigs and are most likely disease-causing strains. 
The finding of strains of non-pathogenic serovars of H. parasuis in sick pigs on 
Farms 14, 16, 17 and 19 complicates the correlation between sick pigs and the 
presence of the disease-associated serovars of H. parasuis in the nasal cavity noted 
on the first 13 farms.  However, there might be other explanations for these 
findings of non-pathogenic serovars in sick pigs.  One explanation could be that the 
“sick” pigs with non-pathogenic serovars were not suffering from Glässer’s disease.  
On Farm 17 the non-pathogenic serovar was isolated from a pig out of a shed that 
had no sick pen and pigs were quickly chosen based on poor condition or coughing.  
On Farm 20 it certainly seems that none of the sick pigs suffered from Glässer’s 
disease as the necropsy samples revealed Actinobacillus pleuropneumoniae, but 
not H. parasuis.  The serovar 9 isolate on Farm 16 came from a sick pig that also 
had two pathogenic serovars.  It is most likely that the pig was naïve before 
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entering the weaner facility, picked up the serovar 9 together with the pathogenic 
strains and hence became sick due to lack of protection against systemic invasion.   
The other explanation could be that these isolates of so-called “non-pathogenic” 
serovars differ from the formal reference strains that were used in the 
pathogenicity studies described in the literature.  The serovar 7 isolate on Farm 16 
was atypical in terms of the serotyping reaction.  This isolate was identified as 
serovar 7 by the IHA methodology but could not be serotyped by the GD method.  
Similar unusual reactions occurred with the isolate of non-pathogenic serovar 6 on 
Farm 14 – with no reaction in the IHA but a reaction in the GD method.  It is 
possible that these “atypical” isolates are not truly non-pathogenic. 
The multiplicity of serovars on Farm 9 and 15 were higher than other researchers 
have observed.  Smart et al. (1988) observed that most farms harboured two to 
four strains.  The other farms in the current studies conform with the observation 
of Smart et al. (1988).  Oliveira et al. (2003)  looked at 10 herds in America and 
recovered 1 to 3 serovars per herd. 
Our results suggest that the serovar can change in time if certain strains are used 
for vaccination.  As an example on Farm 13, the vaccine strain on farm 13 was 
found in one of nine sick pigs and none of the weaned pigs.  In similar light, after 
vaccination with the NT serovar on Farm 10 one group of seven sick pigs had 
serovar 4 only, which was not the dominant serovar before vaccination.  These 
changes in serovar prevalence might have to do with the normally low prevalence 
of pathogenic strains in healthy animals (Oliveira and Pijoan 2002), while diseased 
animals might have a higher prevalence of pathogenic strains and cause a higher 
spread of these strains.  A study by Olvera et al. (2007) found that the diversity of 
strains isolated on a farm was affected by antimicrobial treatment.  Immediately 
following antibiotic treatment, they could only recover one of the three strains 
present on the farm before antimicrobial treatment and this strain was resistant to 
the antibiotic used.  However, one year after treatment the diversity of the strains 
was back to the diversity before the treatment.  This would suggest that the 
susceptible strains were still there at low prevalence and it stresses the importance 
of serovar profiling to find all the strains that are potentially disease causing 
organisms.  Overall, the results from farms where sick pigs were sampled indicate 
that both methods (swabbing healthy weaned pigs and sick pigs) should be 
combined to enhance results of the profiling. 
On Farm 13 the genotype of serovar 4 isolate found in the lungs was a different 
genotype from the serovar 4 isolate found in the nasal cavity of diseased pigs.  
However, nasal sampling the pigs at a later stage did yield an isolate of the same 
genotype as the lung samples.  This suggests again that sample size is important, 
especially if more than one serovar is causing Glässer’s disease on the farm.  
Sampling lung samples and nasal cavity at the same time on Farm 15 revealed that 
the serovar might not necessarily be the same from both sampling sites.  The 
explanation for this might be that several serovars cause the disease.  Hence, 
multiple nasal samples might have yielded the pathogenic isolates found in the 
lung.  The finding that multiple strains can be found in the lung indicating that 
more than one strain can be involved in a clinical outbreak as has been reported 
previously by Olvera et al. (2006). 
This study found only two different genotypes for some serovars, while other 
authors have discovered a much higher genetic diversity within serovars (Oliveira 
et al. 2003) 
In summary, H. parasuis was found on farms where no outbreak occurred.  Isolates 
of serovars recognised as being pathogenic can be easily missed if another strain is 
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more prevalent.  Detection of isolates occurring at a low prevalence requires 
examining multiple colonies per nasal swab.  Sampling healthy weaned pigs does 
not necessarily reveal all pathogenic serovars.  The sample size of pigs is important 
in the detection of strains on a farm.  A bigger sample size of sick pigs on some of 
the farms might have revealed all pathogenic serovars on the farms. 
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Table 1.  Results of swabbing the nasal cavity of pigs from multiparous sows at weaning or 
swabbing pigs with symptoms of disease possibly associated with Glässer’s disease from 20 
farms across Queensland, New South Wales and South Australia.  Pathogenicity was assigned 
to the serovars according to Kielstein and Rapp-Gabrielson.14  Farms with multiple entries 
were sampled at different times.  Necropsy samples came from different pigs to the 
sampled pigs, except on Farms 15 and 16. 
 
potentially 
pathogenic
non-
pathogenic
non-typable or 
pathogenicity 
not referenced
1 30 21-22 days healthy 2 1
2 24 24 days healthy 3 1 1
3 52 3 weeks healthy 5 1 ?/? autogenous sow
3 1 over 5 weeks sick 1 1*
3
23             
23                        
23
34 daysa    
43 days      
72 days                          
healthy
13               
21                     
23 1*
1                       
1                                        
1 
4 30 3 weeks healthy 12 2 1
5 30 3 weeks healthy 11 2 1
6 30 3 weeks healthy 17 2 1 1
7 30 3 weeks healthy 16 1 1 1 ?/?
8 30 3 weeks healthy 17 1 1 1
40 3 weeks healthy 35 3* 2 2 1/1
7 3 - 5 weeks sick 6 2* 1
10 7                   8                           
2 (very sick)
31 days                     
49 days          
28-49 
days                 
sick
4                     
7                      
?b                                                                                  
2* 1 1/1
10
6                             
6                                
7
4 weeks                    
5 weeks          
6 weeks                  
sick
1                    
4                     
4                                                                                 
                                              
2*                    
1
1                                  
1                                                     
-                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
autogenous sow
11 11 3 weeks onwards sick 8 1 1 1/1
12 12 2 - 4 weeks healthy 1 swab 1
31 at weaning healthy 27 1 1
9  ? sick 4 1 2 2/3
13 6 ? sick 2 1* autog. sow/com. piglet
14 25                    5
3 weeks   
5-6 weeks
healthy   
sick
23         
3
2*              
1
1                            
1
1                        
- 3/5
15 10                          20
19 days                              
?     
healthy
sick
7              
13
4*                    
4*
1 4/10
16 38 4 weeks sick 16 3 2* 0/8
17 40 3 - 6 weeks sick 21 1 1 1* 1/5
18 10 ? sick 9 2 2
19 15 6 - 7 weeks sick 12 2 1 2
20 15 ? sick 0 0/2
* one of the serovars has the same genotype as the strain found at necropsy on the farm.
a sampling was done prior to this at 14, 20 and 27 days of age, which yielded no H. parasuis
b isolation of Hps impossible due to proteus contamination
? number with Hps / number necropsied not known. Necropsis done proir to the study period. 
9
13
sick/    
healthy
No. 
with 
Hps
Farm Sample size
Age of 
pigs
autogenous/co
mmercial-
sow/piglet 
vaccine used
autogenous 
sow/commerial 
piglets
No with 
Hps/no 
necropsied
no of serovars recovered                               
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Table 2  Detailed results of farms where a) sampling healthy pigs did not necessary reveal 
all pathogenic strains (Farms 7 and 13), b) sampling sick pigs revealed only pathogenic 
strains or possible pathogenic strains (Farms 3, 9, 10, 11, 13, 15 and 18) and c) sampling 
sick pigs revealed non-pathogenic strains (Farms 14, 16, 17 and 19) 
 
 
 
potentially 
pathogenic non-pathogenic
non-typable or 
pathogenicity 
not referenced
7 30 healthy 16 4 9 NT 12
13 31 healthy 27 9 NT 
9  sick 4 4 4/7,10/13/4 4
13 6 sick 2 4 *
3 1 sick 1 4* 4
9 40 healthy 35 5, 10, 15* 6, 9 NT, 9/13 15
7 sick 6 12, 15* NT
10 15 sick 11 4*, 15 NT 4
10 19 sick 9  4*, 15 NT                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
11 11 sick 8 15 NT                                                                          4
15 10 healthy 7 4*, 10, 12, 13 4, 5
20 sick 13 4*, 5*, 10, 
12
4/6
18 10 sick 9 10, 10/6, 10/15, 15
14 25 healthy 23 15*, 5 6 9/13 15, NT
5 sick 3 5 6
16 38 sick 16 4, 10, 12 7, 9 
17 40 sick 21 15 9 NT* NT
19 15 sick 12 4, 15 9 NT, 4/6/7
Serovars recovered Serovars of 
necropsied sick 
pigs
Farm Sample size
Sick/healt
hy pigs
No. with 
Hps
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Table 3  Details of the serovars and genotypes found on four farms. 
 
  
 
 
Farm Serovars (no of pigs with serovar) Genotypes (for serovar)
3  NT (23)A, 4 (6) 1 (NT)B, 1(4) 
9 6 (10), 10 (9), 9 (5), 9/13 (5), 15 (4), 5 (2),  NT (2) 
1 (5), 1 (6), 1 (9), 1 (9/13), 1 (10), 2 (15), 
1 (NT)  
10 NT (9), 4 (2), 15 (2), 2 (15), 1 (4), 1 (NT)
11  NT (6), 15 (3)                                  2 (15), 1 (NT)
13 NT (19) , 9 (8), 4 (3), 4/7 (1), 10/13/4 (1)                                                       2 (9), 1 (4), 1 (4/7), 1 (10/13/4), 1 (NT)    
15 4 (10), 10 (9), 12 (4), 4/6 (1),  5 (1), 13 (1) 2 (4), 1 (4/6), 1 (5), 1 (10), 1 (12), 1 (13)
16 7 (8), 4 (3), 12 (3), 9 (1), 10 (1) 2 (4), 1 (7), 1 (9), 1 (10), 1 (12)
19 NT (5), 9 (3), 4 (2), 4/6/7 (2), 15 (1), 2 (NT)1 (4), 1 (4/6/7), 1 (9), 1 (15)
A The serovar is presented and then the number of pigs with that serovar is given in brackets.  The 
serovars are ordered according to their prevalence
B The various genotypes are listed with the serovar being presented in brackets.
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Appendix 6 - Validation of a Real Time PCR for 
Haemophilus parasuis 
Introduction 
In 1906, a disease of young pigs associated with polyserositis and arthritis was 
described by Karl Glässer (Sutherland and Simmons 1947).  This disease is now 
known as Glässer’s disease and is caused by the bacterium Haemophilus parasuis 
(Oliveira and Pijoan 2004).  Haemophilus parasuis is a fastidious and delicate 
organism, characteristics which cause problems in the diagnosis of the disease 
(Ferri et al. 2000).  Recommendations on the best sampling sites and on transport 
media for swabs and temperatures are available in the literature and from 
laboratories involved in the processing of samples (Oliveira 2004; Turni and Blackall 
2007a).  However, the conditions in the field are not always optimal, which makes 
culturing samples difficult and creates a dependence on a sensitive and specific 
PCR to use on DNA templates extracted from tissues, fluids and swabs directly.  
The PCR developed by Oliveira et al. (2001) has problems in specificity giving a 
weak positive with Actinobacillus indolicus, lowering the value of the test when it 
is applied to samples from upper respiratory sites where both H. parasuis and A. 
indolicus can be present (Oliveira et al. 2001).  The PCR developed by Angen et al. 
(2007) does not report problems with specificity, but seems not as sensitive as the 
one of Oliveira et al. (2001) (Angen et al. 2007).  The PCR of Oliveira et al. (2001) 
can detect a minimum concentration of 1 x 102 cfu ml-1 of H. parasuis (Oliveira et 
al. 2001).  When the conventional PCR of Oliveira et al. (2001) was compared to 
the culture method for swabs taken from pigs challenged with H. parasuis, the 
culture method was more sensitive than the conventional PCR (Turni and Blackall 
2007a).  According to Espy et al. (2006) the sensitivity of the real time PCR is in 
some cases greater than the conventional methods used for bacteriological 
diagnostics (culture and conventional PCR).  A real time PCR has the potential to 
be highly sensitive and specific (Espy et al. 2006; Mackay 2004; Valasek and Repa 
2005).   
The primers developed for the two conventional PCRs for H. parasuis target the 16S 
ribosomal RNA gene, which is conventionally used as a taxonomic and phylogenetic 
marker (Wilson et al. 1990).  However, a preliminary study in our laboratory could 
not differentiate Pasteurella mairii from H. parasuis for the short amplification 
product of the real time PCR technology selected, when using the 16S rRNA as the 
target.  A possible alternate gene to the 16S rRNA gene is the infB gene.  
Hedegaard et al. (2000) concluded that the infB gene might be useful as a genetic 
marker for phylogenetic studies.  The infB gene codes for the two forms of the 
translation initiation factor IF2 – IF2 alpha and IF2 beta (Hedegaard et al. 2000). 
This paper describes a real time PCR method developed at the Animal Research 
Institute targeting the infB gene of H. parasuis.  The validation of this method 
includes the testing of DNA from H. parasuis reference and field strains, DNA from 
closely related bacterial species and DNA extracted from swabs of tissue and fluids 
and from fluid and tissue samples from seven serovar 12 and nine serovar 4 
experimentally challenged pigs. 
Material and Methods 
Bacteria 
To determine the specificity of the real time PCR, a total of 68 H. parasuis strains 
covering all 15 recognised serovars were tested.  This selection included 15 
reference strains, the taxonomic type strain, 42 Australian field isolates collected 
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from 13 farms representing 10 identified serovars and 10 isolates from Denmark 
representing 9 serovars.  All isolates/strains were identified by the PCR of Oliveira 
et al. (2001) and serotyped according to the method by Turni and Blackall (2005).  
A total of 36 non-H. parasuis isolates covering 24 species were used.  Tables 1 and 
2 provide the details of the isolates used in this study. 
A conventional PCR targeting the nuclear ribosomal RNA 16S rRNA gene with 
universal bacteria primers (5’ GAGTTTGATCCTGGCTCAG  3’ and 5’ 
AAGGAGGTGWTCCARCC 3’) was performed on the template of all bacterial species 
other than H. parasuis to confirm that the template was suitable for use in PCR.  
The 16S PCR was run as described by Miflin and Blackall (2001) with the exception 
that the mix was briefly UV irradiated before the primers and template were added 
to the mix to inactivate any contaminating DNA. 
Clinical samples 
The clinical samples examined were generated in previously described experiments 
that used 16 naturally farrowed, colostrum deprived pigs subjected to intra-
tracheal challenge with either H. parasuis serovar 4 (HS 1387) or serovar 12 (H425) 
(Turni and Blackall 2007a).   
DNA preparation from bacterial isolates and samples from challenged animals 
Bacteria species were grown on BA/SN (Turni and Blackall 2007b) overnight and a 1 
µl loopful of growth was suspended in 100 µl of water.  The suspension was heated 
at 98°C for 5 min, followed by cooling on ice for 5 min.  After centrifugation for 5 
min at 17,380 x g, the supernatant was collected and stored at -20°C.  A 1 µl 
aliquot of the supernatant was used for PCR analysis.  Alternatively, 1 µl loop of 
growth was suspended in 200 µl of PrepMan Ultra (Applied Biosystems, Foster City 
CA) and boiled for 10 min suspended in boiling water.  After cooling the suspension 
for 3 min, the suspension was spun at 17,380 x g for 3 min and the supernatant 
collected and stored at -20°C until use.    
DNA from the swab, tissue and fluid samples of the H. parasuis challenged animals 
were prepared with the PrepMan Ultra method as previously described by Turni and 
Blackall (2007a).  
Real time PCR 
Available sequences of the infB gene of H. parasuis (gene bank accession numbers: 
DQ781806, DQ781808, DQ781810 - DQ781817) and related species (accession 
numbers: DQ211781 - Actinobacillus rossii, DQ211790 - Pasteurella mairii, 
DQ211791 - P. aerogenes, EF059970 - A. porcinus, EF059971 - A. indolicus) on 
GenBank were aligned with the software Sequencher 4.5 (Gene Code Corporation, 
Ann Arbor, MI).  Primers and probes were designed for a species-specific region of 
the gene with the Primer Express® Software (Applied Biosystems, CA, USA). The 
primers designed were the forward primer CTinfF1: 5’ 
CGACTTACTTGAAGCCATTCTTCTT 3’ and reverse primer CTinfR1: 5’ 
CCGCTTGCCATACCCTCTT 3’, which target the 392 to 466 base pair region of the 
gene.   The FAM labelled TaqMan probe with a TAMRA quencher was supplied by 
Applied Biosystems (CA, USA) with the following sequence CTinfP  5’ 6FAM-
ATCGGAAGTATTAGAATTAAGTGC –TAMRA 3’. The 25 µl reaction mix consisted of 7 
µl of H2O, 10 µl of 5 Prime RealMasterMix Probe (Quantum Scientific, Milton, QLD, 
Australia), 100 nmol l-1 CTinfF1, 400 nmol l-1 CTinfR1, 100 nmol l-1 of CTinfP and 5 
µl of template (maximum concentration of 200 ng µl-1).  The template was diluted 
one in ten if DNA was prepared from a culture plate.  The reaction was run on a 
Corbett Rotor-Gene 3000 (Corbett, Mortlake, NSW Australia) real time thermal 
cycler with the following cycling conditions:  first cycle at 95˚C for 2 min, followed 
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by 45 cycles of 95˚C for 20 sec and 58˚C for 60 sec, this is then followed by one 
cycle at 28˚C for 1 min.  Fluorescence data were acquired once every cycle at the 
end of the extension phase.  The amplified product was 74 base pairs long.   
Sensitivity of the real time PCR 
Growth of H. parasuis CCUG3712T was harvested from an overnight incubated NADH 
supplemented chocolate agar plate (Turni and Blackall 2007a) into phosphate 
buffered saline (PBS) and the concentration of the suspension was adjusted to 
approximately 1.8 x 108 cfu ml-1.  The concentration of the suspension was 
confirmed by viable counts performed on chocolate blood agar that were incubated 
for 24 hour.  The suspension was then diluted in a 10 fold series in PBS to give 
dilutions containing 100 to 105 cfu ml-1.  A 1 ml aliquot of each dilution was used to 
extract DNA with the PrepMan Ultra method and 100 µl of each dilution was used to 
extract DNA with the boiling and cooling method.  The extraction of DNA was done 
in triplicate for each method and each dilution.  The sensitivity experiment was 
repeated for the boiling and cooling method.  The sensitivity was also tested for 
dilutions of H. parasuis that also contained 1.265 x 108 Escherichia coli per 
dilution.  Furthermore, the sensitivity was tested by diluting H. parasuis in 
pericardial fluid from healthy pigs instead of PBS.   
Sensitivity was also tested for three serovar reference strains of H. parasuis:  SW 
124 (serovar 4 regarded as moderately pathogenic), Nagasaki (serovar 5 regarded 
as highly pathogenic) and 174 (serovar 7 regarded as non-pathogenic).  The 
harvested growth was again adjusted to approximately 1.8 x 108 cfu ml-1 and the 
concentration confirmed by viable count.  However, instead of diluting the cell 
suspension the DNA was extracted with both methods from the original suspension.  
After determining the DNA concentration with a spectrophotometer the DNA 
suspensions were then 10 fold serial diluted with sterile H2O. 
Genotyping of H. parasuis field isolates with ERIC PCR 
All 42 Australian and the 10 Danish field isolates of H. parasuis were genotyped to 
determine the number of different genotypes present in the collection. The 
Enterobacterial Repetitive Intergenic Consensus (ERIC) PCR, performed as 
previously described by Oliveira et al. (2003), was used to genotype the isolates.  A 
dendrogram was constructed with the Bionumeric software (Bionumeric version 
4.50, Applied Maths Inc, Sint-Martens-Latem, Belgium).  Visual comparison of the 
band pattern was used to determine the similarity cutoff point. 
Comparison of PCR results using clinical sourced material 
The real time PCR was run on DNA samples from a previous challenge experiment 
performed by Turni and Blackall (2007a).  This challenge experiment was set up in 
two parts:  in the first trial seven naïve animals were challenged with serovar 12, 
while in the second trial nine naïve animals were challenged with serovar 4.  Tissue 
and fluid samples were taken from these animals two to seven days after 
challenge.  These tissue and fluids were processed in two different ways:  one 
sample was cultured, while the other sample was processed for PCR.  Two different 
samples were taken for PCR:  one was a swab from tissue or fluid and the other was 
the tissue and fluid samples.  In the current work the real time PCR was run on DNA 
that had been stored at -20°C from these challenge trials.  The results of the real 
time PCR were compared to results of the conventional PCR of Oliveira et al. 
(2001) and to results of the culture method, both of which have been reported 
previously (Turni and Blackall 2007a). 
DNA was tested from tissue and fluids swabs of the brain, mandibular lymph node, 
trachea, lung, pleural fluid, pericardial fluid, heart, liver, peritoneal fluid, fibrin in 
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the peritoneum and joint or synovial fluid for both the serovar 12 and 4 challenge.  
The other types of samples analysed were DNA obtained from tissue samples from 
tonsils (only serovar 12), trachea, lung, heart, lymph node and brain for animals 
challenged with either serovar 12 or 4.  In addition fluid samples (peritoneal, 
pleural, pericardial, articular and cerebrospinal) were obtained and DNA extracted 
from these samples in the serovar 4 challenge experiment.  In the serovar 4 
challenge no culture was performed on the tissue and fluid samples that were 
processed directly for DNA. 
A total of 71 and 90 samples of DNA from swab of tissue and fluids were analysed 
from serovar 12 and 4 challenge experiments, respectively.  For the tissue and fluid 
samples a total of 26 and 52 samples of DNA were processed from serovar 12 and 4 
challenge experiment, respectively. 
Statistics 
A generalized linear mixed model with method (real time PCR/PCR/culture), 
serovar, tissue and interaction as fixed effects and animal within serovar as a 
random effect was fitted to the data assuming a binomial error distribution with a 
logit link function.  Pair-wise differences between means of the logits were tested 
using a protected least significance difference procedure (P = 0.05).  All analysis 
was done using GenStat (Statistics. VSN International, Hemel Hempstead). 
Results 
Validation of Real Time PCR method 
The infB gene gave good separation for H. parasuis from the closely related 
bacterial species tested in this study.  None of the closely related species amplified 
in the real time PCR.  All 15 reference strains, the type strain, the 42 Australian 
and 10 Danish field isolates of H. parasuis tested gave positive results with the real 
time PCR.   
Visual examination of the dendrogram, constructed from the ERIC PCR gel profile 
of the 42 Australian and 10 Danish field isolates, showed that a >96 % similarity cut-
off was appropriate for recognizing genotypes and 46 genotypes were recognized 
amongst the 52 Australian and Danish field isolates. 
Sensitivity 
The C t sc ores and t he c oncentrations o f t he r eaction m ix f or w hich al l t hree 
samples y ielded a po sitive r esult f or t he CCUG3712 ar e sho wn i n Table 3 .  T he 
results for the three other serovar reference strains of H. parasuis tested are also 
shown.  Fr om these data the cut-off points for a po sitive were determined.  T he 
cut-off po ints for the questionable and ne gative Ct scores were determined f rom 
the Ct values where not all three replicates of CCUG3712 yielded uniform positive 
results (data not shown).  The positive cut-off point was selected as the highest Ct 
score shown in Table 3.  Hence, the selected cut-off points were as follows: 
Positive - a Ct score up to 42 
Questionable - a Ct score of 43 to 45 
Negative - a Ct score above 45 
Real Time PCR compared to conventional PCR and culture method 
Overall, the real time PCR from 161 swabs of tissue and fluid gave a total of 50 
(31.06%) more positive results than the conventional PCR over the two challenge 
trials and 14 (8.70%) more positive results than the culture method (Table 4).  The 
difference between the real time PCR and the conventional PCR were statistically 
significant for both serovar challenges.  In the serovar 12 challenge the real time 
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PCR had 37 (52.11%) more positives than the conventional PCR.  In serovar 4 
challenge the difference was only 13 (14.45%) more positive results (Table 4). 
When the real time PCR was run with the DNA obtained from tissue and fluid 
samples the real time PCR obtained significantly more positive results than the 
conventional PCR and the culture method (Table 4).  
A more detailed analysis of the instances where the real time PCR gave a positive 
result with samples that were negative by culture is presented in Table 5.  Many of 
the culture negative/real time PCR positive samples involved the tonsils.  The Ct 
scores for tonsil swab samples, which came up negative in culture, ranged from 
26.95 to 36.05, while the Ct scores from tonsil samples ranged from 29.43 to 38.34.  
A closer look at data from Table 4 reveals that swabs from tonsils gave six positive 
results out of six samples for the real time PCR and three for the conventional PCR 
for serovar 12.  For serovar 4 the real time PCR produced nine positive results out 
of nine tonsil swab samples and the conventional PCR produced seven positive 
results.  When the tonsil tissue was processed directly the real time PCR produced 
seven positive results out of seven samples and three positive samples for the 
conventional PCR for the serovar 12 challenge.  Cultures on the tonsils were mostly 
overgrown and a sweep was performed on the growth which was analysed with a 
conventional PCR (Turni and Blackall 2007a).  If the conventional PCR came up 
negative the culture was called negative.  From the analysis of the real time PCR it 
becomes apparent that this sweep method with the conventional PCR is not 
sensitive enough to detect low numbers of H. parasuis in the sweep. 
Discussion 
A real time PCR was developed with primers that target the infB gene.  The 
commonly used 16S rRNA gene was not species-specific to separate H. parasuis 
from the other closely related species for the short amplification sequence of a 
real time PCR (data not shown).  No region could be found within the 16S rRNA 
gene where the primer sequences for H. parasuis were sufficiently different from 
other species. 
While studying the infB gene as a possible tool to study the population structure of 
Streptococcus agalactiae, Hedegaard et al. (2000) discovered that the infB gene 
revealed limited intra-species diversity within S. agalactiae.  Hedegaard et al. 
(2000) concluded that the infB gene is useful as a genetic marker for phylogenetic 
studies of species.  This observation that the infB gene can separate species has 
also held true for H. parasuis in the current study.  The gene proved to be a good 
target for real time PCR primers for H. parasuis, separating H. parasuis from all 
other closely related species.  The intra-species variation of the infB gene also 
seems to be very limited for H. parasuis.  All of the 42 field samples and 10 Danish 
isolates, which represented 46 different genotypes, as well as all 15 serovar 
reference strains and the taxonomic type strain (CCUG3712), amplified with the 
primers targeting the infB gene. 
The isolation of H. parasuis is difficult, as the bacterium is very sensitive to pH 
changes and heat (Morozumi and Hiramune 1982).  H. parasuis is also a slow 
growing, fastidious organism with specific nutritional requirements (Ferri et al. 
2000; Oliveira and Pijoan 2004).  This makes recovery of the organism after sample 
collection and transport to the laboratory very difficult.  Once in the laboratory the 
isolation is very difficult as H. parasuis is easily overgrown by other faster growing 
bacteria.  Therefore, the method of identification by culture is not always optimal 
and PCR-based methods are an attractive alternative.   The available conventional 
PCR assays; display problems with non-specific bands (Oliveira et al. 2001) or 
sensitivity (Angen et al. 2007).  The real time PCR method described here is more 
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specific and does not give a positive reaction with any of the 24 non-target species 
(including all close relatives) tested.  Oliveira et al. (2001) reported a sensitivity of 
0.5 cfu per reaction, while Angen et al. (2007) reported a sensitivity of 5.3 cfu per 
reaction for their PCR.  According to our sensitivity assays, the real time PCR 
showed a sensitivity of 9.5 to 0.83 cfu per reaction for the boiling method of DNA 
extraction and 47.5 CFU per reaction to 0.42 cfu per reaction for the PrepMan Ultra 
method.  However, when looking at the data from the challenged animals, where 
the Oliveira et al. (2001) PCR was used, the real time PCR gave significantly higher 
numbers of positive results.  Overall, our data indicate that the real time PCR is 
more sensitive than the conventional PCR, even though our minimum detectable 
cfus per reaction were higher than the reported minimum detectable cfus of the 
conventional PCR (Oliveira et al. 2001).  
In a study by Turni and Blackall (2007a) the culture method was deemed more 
successful than the conventional PCR method when detecting H. parasuis in sick 
animals.  The results of the current study indicate that this does not hold true for 
the real time PCR.  The real time PCR performed better than culture, although not 
at a statistically significantly level for the DNA from swab samples.  In laboratories 
where the culture methods are not as optimized as in our laboratory, the real time 
PCR should perform even better compared to culture.  Therefore, we believe that 
real time PCR will enhance the diagnosis of H. parasuis, especially for laboratories 
that are not experienced with the culture of H. parasuis or in situation where 
culture is not possible. 
Strains of H. parasuis can be easily found in the nasal cavity of sick pigs (Turni 
2009).  However, nasal swabs are not suitable for use in the conventional PCR of 
Oliveira and Pijoan (2004) as that PCR gives false positive reactions with 
A. indolicus, an organism known to be present in the upper respiratory tract of pigs 
(Oliveira and Pijoan 2004).  However, as the real time PCR described in this study 
does not give false positives for A. indolicus, it is possible to use this assay on nasal 
swabs or other upper respiratory tract samples.  From the results of the current 
study it is apparent that the conventional PCR also has problems in detecting the 
presence of H. parasuis in overgrown cultures and that the use of sweep method 
and subsequent conventional PCR analysis (as performed on overgrown culture 
plates in this study) is not an effective method for the detection of H. parasuis.  
The Ct scores of the real time PCR assays on the tonsil samples indicate that there 
were sufficient numbers of bacteria in the tissue to indicate that sufficient 
numbers of H. parasuis were present and that these organisms should have been 
transferred to the culture plate and should have been present in the subsequent 
plate sweeps used as a source for the conventional PCR.  This problem of the 
conventional PCR (low sensitivity in the presence of other bacteria) is overcome 
with the real time PCR.  The sensitivity assay revealed that the real time PCR 
detected low numbers of H. parasuis even in the presence of large numbers of non 
target cells.  The ability of the real time PCR to perform well in the presence of 
large number of other bacteria was seen in the results obtained from the samples 
processed from the tonsils of the challenged animals.  The real time PCR 
significantly outperformed the conventional PCR-culture method. 
When using this real time PCR assay as a diagnostic tool it has to be pointed out 
that the presence of H. parasuis in the upper respiratory tract does not mean that 
there is a problem with H. parasuis, as non-pathogenic serovars can be found in the 
upper respiratory tract.  Therefore, if the real time PCR is used as the diagnostic 
tool to determine the cause of disease, the assay should be used from samples 
from internal organs and tissues. 
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In conclusion, the infB gene targeted real time PCR for H. parasuis performed well 
for pure culture, swabs from tissue and fluid or tissue and fluid processed directly 
regardless of contamination by other bacterial species.  The high sensitivity and 
specificity of the real time PCR make it an ideal diagnostic tool for H. parasuis.  
The real time PCR has distinct advantages over conventional PCR - less risk of non-
specific binding and contamination, less handling time (no post reaction analysis) 
and the potential of high throughput automation. 
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Figure 1 Dendrogram showing the clustering of ERIC PCR finger-prints of 42 Australian and 
10 Danish field isolates of H. parasuis.  Using a cut-off of 96% similarity, a total of 46 
genotypes were recognised 
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Table 1.  H. parasuis strains used to validate the specificity of the real time PCR 
Strain* Serovar Description 
NR4 1 Serovar Reference 
SW140 2 Serovar Reference 
SW114 3 Serovar Reference 
SW124 4 Serovar Reference 
Nagasaki 5 Serovar Reference 
131 6 Serovar Reference 
174 7 Serovar Reference 
C5 8 Serovar Reference 
D74 9 Serovar Reference 
H367 10 Serovar Reference 
H465 11 Serovar Reference 
H425 12 Serovar Reference 
IA-84-17975 13 Serovar Reference 
IA-84-22113 14 Serovar Reference 
IA-84-15995 15 Serovar Reference 
CCUG3712  Type Strain 
Field isolate (1)* 1 NC – healthy pig (D)† 
Field isolate (1) 1/11 NC – sick pig (B) 
Field isolate (1) 2/1 NC – healthy pig (D) 
Field isolates (9) 4 NC – healthy pig (D) 
NC – sick pig (A, E, G, H, M) 
Lung (K, Q) 
Trachea (K) 
Field isolate (1) 4/11 NC – healthy pig (D) 
Field isolates (4) 5 NC – healthy pig (D, F) 
NC – sick pig (L) 
Lung (P) 
Field isolate (1) 6 NC – healthy pig (N) 
Field isolate (1) 6/10 NC  – sick pig (I) 
Field isolate (1) 7 NC  – sick pig (E) 
Field isolates (4) 9 NC – healthy pig (C, N) 
NC – sick pig (H) 
Lung (E) 
Field isolate (3) 10 NC – healthy pig (C) 
NC – sick pig (E, I) 
Field isolate (3) 12 NC – healthy pig (L) 
NC – sick pig (E) 
Lung (R) 
Field isolate (1) 13 Lung (O) 
Field isolate (4) 15 NC – healthy pig (C) 
NC – sick pig (J, K) 
Lung (F) 
Field isolates (7) NT NC – healthy pig (D, F, G) 
NC – sick pig (H, J, K) 
Lung (F) 
Danish field isolates (10) 2, 3, 9, 11, 12, 13, 14, 15, 
NT 
Two isolates of serovar 11 
* The number of field isolates in each category is given in brackets. 
† NC stands for nasal cavity, Farms are labelled from A to R and is indicated in brackets 
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Table 2. Non-H. parasuis strains used to validate the specificity of the real time PCR 
 
Species Strain Description 
Actinobacillus capsulatus BR515A Field isolate 
Actinobacillus equuli CCUG 2401A Type strain 
 BR92 Field isolate 
Actinobacillus indolicus CCUG39029A Type strain 
 HS2394 Field isolate 
Actinobacillus ligniersii BR453A Field isolate 
Actinobacillus minor CCUG38923A Type strain 
 HS2189 Field isolate 
Actinobacillus 
pleuropneumoniae 
Shope 4074A Type and serovar 1 reference strain 
 K17 Serovar 5 reference strain 
 WF83 Serovar 7 reference strain 
 1096 Serovar 12 reference strain 
 HS143 Serovar 15 reference strain 
 HS2924 Field isolate 
Actinobacillus porcinus CCUG38924A Type strain 
 HS2108 Field isolate 
Actinobacillus rossi CCUG12395 Type strain 
 BR488A Field isolate 
Actinobacillus suis CCUG11624A Type strain 
Bibersteinia trehalosi BR458 Field isolate 
Bordetella bronchiseptica BR467A Field isolate 
Bisgaard Taxon 8 / 
A. equili/A. arthritidis 
BR509 Field isolate 
Escherichia coli BR494A Field isolate 
Haemophilus parainfluenzae NCTC7857A Type strain 
Mannheimia haemolytica CCUG408A Type strain 
 BR441 Field isolate 
Mannheimia varigena CCUG38462A Type strain 
Pasteurella aerogenes CCUG9995A Type strain 
Pasteurella canis NCTC11621A Type strain 
Pasteurella langaaenis NCTC11411A Type strain 
Pasteurella mairii CCUG27189A Type strain 
 BR133 Field isolate 
Pasteurella multocida NCTC10322 Type strain 
Pasteurella stomatis NCTC11623A Type strain 
Pasteurella species B SSIP683A Reference strain 
Streptococcus suis CCUG7984A Type strain 
AIndicates that both DNA extraction methods were used with this strain/isolate 
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Table 3.  Results of sensitivity testing of real time PCR for H. parasuis 
 
 
* For CCUG3712, reactions were performed in triplicate while single reactions were used for all other strains.  For CCUG3712, the lowest dilution at 
which all three replicates were positive was defined as the minimum positive dilution. 
Strain DNA extraction method 
Cell count in positive reaction  at minimum 
positive concentration 
Ct score of minimum 
positive 
concentration 
DNA 
concentration 
(ng ul-1) of 
original solution 
Cell count (cfu 
ml-1) of original 
solution 
CCUG3712* PrepMan Ultra 47.5 cfu 37.12 ± 0.63 - 1.9 x 108 
CCUG3712* Boiling/cooling 9.5 cfu 37.04 0.51 - 1.9 x 108 
 
CCUG3712* 
(Repeat) 
 
Boiling/cooling 
 
2.45 cfu 
 
38.20 ± 0.55 
-  
0.49 x 108 
CCUG3712* 
+ 1.265 x 108 E. 
coli 
Boiling/cooling 2.45 cfu 38.06 ± 0.49 - 0.49 x 108 
CCUG3712* 
+ Pericardial fluid 
Boiling/cooling 2.45 cfu 39.17 ± 2.35 - 0.49 x 108 
SW124 Boiling/cooling 9.5 cfu 38.42 14.9 1.9 x 108 
Nagasaki Boiling/cooling 9.5 cfu 38.06 10.9 1.89 x 108 
174 Boiling/cooling 0.83 cfu 42.71 11.6 1.66 x 108 
SW124 PrepMan Ultra 0.48 cfu 37.90 65.7 1.9 x 108 
Nagasaki PrepMan Ultra 0.47 cfu 40.02 49.7 1.89 x 108 
174 PrepMan Ultra 0.42 cfu 42.46 55.4 1.66 x 108 
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Table 4.  Positive and negative results from all swab samples from tissue and fluid compared by the three methods for the two experimental challenge 
trials.  Positive and negative results from all tissue and fluid samples are compared for the three methods in the two challenges.  In the serovar 4 
challenge, tissue and fluid were not cultured.  Different letters indicate a statistical significant difference between the data 
 
Sample type Challenge type Number of positive results* Number of 
samples Real-time PCR PCR# Culture# 
Swab of tissue/fluid Serovar 12 64 (90)a 27 (38)b 57 (80)a 71 
 Serovar 4 43 (48)a 30 (33)b 36 (40)a,b 90 
 Total 107 (66)a 57 (35)b 93 (58)a 161 
      
Tissue/fluid Serovar 12 26 (100)a 11 (42)b 9 (35)b 26 
 Serovar 4 32 (62)a 18 (35)b - 52 
 Total 58 (74)a 29 (37)b - 78 
* Result in brackets is percentage. 
# Previously published results see Turni and Blackall (2007a) 
 
 
Table 5.  Samples of tissues and fluid for which the real time PCR produced a positive result yet the culture method gave a negative result.  For the 
tonsils most of the cultures were overgrown and a conventional PCR was performed on the mixed growth, if the PCR came up negative the culture was 
called negative 
 
Sample Type Challenge 
Serovar 
Number of tissues that were positive in real-time PCR but negative by culture (total number sampled) 
Brain Heart Joint Lung Lymph 
Node 
Pericardial 
Fluid 
Peritoneal 
Fibrin 
Peritoneal 
Fluid 
Pleural 
Fluid 
Tonsil 
Swabs 12 0 (7) 0 (5) 0 (6) 0 (7) 1 (6) 1 (7) 2 (6) 2 (6) 1 (4) 4 (6) 
 4 2 (9) 2 (9) 1 (9) 0 (9) 1 (9) 1 (9) - 1 (9) - 5 (9) 
            
Tissue/Fluid 12 1 (2) 0 (1) - 6 (7) 2 (3) - - - - 7 (7) 
 
